Table of Contents

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 


 

FORM 10-Q

 


 

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended October 31, 2004

 

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from              to             

 

Commission File Number 000-10761

 


 

LTX CORPORATION

(Exact Name of Registrant as Specified in Its Charter)

 


 

Massachusetts   04-2594045

(State or Other Jurisdiction of

Incorporation or Organization)

 

(I.R.S. Employer

Identification No.)

 

50 Rosemont Road,

Westwood, Massachusetts

  02090
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s Telephone Number, Including Area Code (781) 461-1000

 

 

Former Name, Former Address and Former Fiscal Year,

if Changed Since Last Report.

 


 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days    Yes   x     No   ¨

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Exchange Act Rule 12b-2 of the Exchange Act).    Yes   x     No   ¨

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

 

Class


  

Outstanding at November 30, 2004


Common Stock, par value $0.05 per share    61,167,882

 



Table of Contents

LTX CORPORATION

 

Index

 

        

Page

Number


Part I.   FINANCIAL INFORMATION     
Item 1.   Consolidated Balance Sheets October 31, 2004 and July 31, 2004    3
    Consolidated Statements of Operations and Comprehensive Income Three Months Ended October 31, 2004 and October 31, 2003    4
    Consolidated Statements of Cash Flows Three Months Ended October 31, 2004 and October 31, 2003    5
    Notes to Consolidated Financial Statements    6-12
Item 2.   Management’s Discussion and Analysis of Financial Condition and Results of Operations    12-22
Item 3.   Quantitative and Qualitative Disclosures About Market Risk    22
Item 4.   Controls and Procedures    22
Part II.   OTHER INFORMATION     
Item 4.   Submission of Matters to a Vote of Security Holders    23
Item 5.   Other Information    24
Item 6.   Exhibits and Reports on Form 8-K    24
    SIGNATURE    25

 

2


Table of Contents

LTX CORPORATION

 

CONSOLIDATED BALANCE SHEETS

(In thousands)

 

     October 31,
2004


    July 31,
2004


 
     (Unaudited)        

ASSETS

                

Current assets:

                

Cash and cash equivalents

   $ 59,692     $ 95,112  

Marketable securities

     146,573       149,601  

Accounts receivable, net of allowances

     26,009       32,961  

Accounts receivable – other

     7,449       11,494  

Inventories

     40,554       69,220  

Prepaid expense

     7,423       9,828  
    


 


Total current assets

     287,700       368,216  

Property and equipment, net

     72,760       71,329  

Goodwill and other intangible assets

     15,588       15,763  

Other assets

     3,933       4,256  
    


 


Total assets

   $ 379,981     $ 459,564  
    


 


LIABILITIES AND STOCKHOLDERS’ EQUITY

                

Current liabilities:

                

Current portion of long-term debt

   $ 162     $ 321  

Accounts payable

     21,017       37,438  

Deferred revenues and customer advances

     3,087       3,520  

Deferred gain on leased equipment

     6,298       6,852  

Other accrued expenses

     26,436       27,179  
    


 


Total current liabilities

     57,000       75,310  

Long-term debt, less current portion

     150,000       150,000  

Stockholders’ equity:

                

Common stock

     3,045       3,045  

Additional paid-in capital

     555,457       555,447  

Unrealized gain (loss) on marketable securities

     284       (106 )

Accumulated deficit

     (385,805 )     (324,132 )
    


 


Total stockholders’ equity

     172,981       234,254  
    


 


Total liabilities and stockholders’ equity

   $ 379,981     $ 459,564  
    


 


 

See accompanying Notes to Consolidated Financial Statements

 

3


Table of Contents

LTX CORPORATION

 

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME

(Unaudited)

(In thousands, except per share data)

 

    

Three Months Ended

October 31,


 
     2004

    2003

 

Net product sales

   $ 34,743     $ 37,523  

Net service sales

     8,290       9,096  
    


 


Net sales

     43,033       46,619  

Cost of sales

     28,234       32,523  

Inventory related provision

     47,457       —    
    


 


Gross profit (loss)

     (32,658 )     14,096  

Engineering and product development expenses

     17,640       16,579  

Selling, general and administrative expenses

     7,879       6,382  

Reorganization costs

     3,115       —    
    


 


Loss from operations

     (61,292 )     (8,865 )

Other income (expense):

                

Interest expense

     (1,663 )     (1,714 )

Investment income

     1,282       773  
    


 


Net loss

   $ (61,673 )   $ (9,806 )
    


 


Net loss per share:

                

Basic

   $ (1.01 )   $ (0.19 )

Diluted

   $ (1.01 )   $ (0.19 )

Weighted-average common shares used in computing net loss per share:

                

Basic

     60,987       51,797  

Diluted

     60,987       51,797  

Comprehensive loss:

                

Net loss

   $ (61,673 )   $ (9,806 )

Unrealized gain (loss) on marketable securities

     390       (171 )
    


 


Comprehensive loss

   $ (61,283 )   $ (9,977 )
    


 


 

See accompanying Notes to Consolidated Financial Statements

 

4


Table of Contents

LTX CORPORATION

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(In thousands)

 

    

Three Months Ended

October 31,


 
     2004

    2003

 

CASH FLOWS FROM OPERATING ACTIVITIES:

                

Net loss

   $ (61,673 )   $ (9,806 )

Add (deduct) non-cash items:

                

Depreciation and amortization

     3,911       4,663  

Charge for inventory related provision

     47,457       —    

Other

     (34 )     29  

(Increase) decrease in:

                

Accounts receivable

     11,102       (4,816 )

Inventories

     (18,711 )     4,181  

Prepaid expenses

     2,515       (1,083 )

Other assets

     406       559  

Increase (decrease) in:

                

Accounts payable

     (16,490 )     1,999  

Accrued expenses

     (876 )     2,232  

Deferred revenues and customer advances

     (997 )     (2,057 )
    


 


Net cash used in operating activities

     (33,390 )     (4,099 )

CASH FLOWS FROM INVESTING ACTIVITIES:

                

Purchases of marketable securities

     (24,718 )     (22,737 )

Proceeds from sale of marketable securities

     27,747       26,326  

Purchases of property and equipment

     (4,888 )     (3,972 )
    


 


Net cash used in investing activities

     (1,859 )     (383 )

CASH FLOWS FROM FINANCING ACTIVITIES:

                

Exercise of stock options

     10       1,140  

Payments of short-term notes payable, net

     (55 )     (4 )

Payments of long-term debt

     (106 )     (25 )
    


 


Net cash (used in) provided by financing activities

     (151 )     1,111  

Effect of exchange rate changes on cash

     (20 )     83  
    


 


Net decrease in cash and cash equivalents

     (35,420 )     (3,288 )

Cash and cash equivalents at beginning of period

     95,112       73,167  
    


 


Cash and cash equivalents at end of period

   $ 59,692     $ 69,879  
    


 


SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:

                

Cash paid during the period for interest

   $ 1,678     $ 35  

 

See accompanying Notes to Consolidated Financial Statements

 

5


Table of Contents

LTX CORPORATION

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

1. THE COMPANY

 

LTX Corporation (“LTX” or the “Company”) designs, manufactures, and markets automatic semiconductor test equipment. Semiconductor designers and manufacturers worldwide use semiconductor test equipment to test devices at different stages during the manufacturing process. These devices are incorporated in a wide range of products, including mobile internet equipment such as wireless access points and interfaces, broadband access products such as cable modems and DSL modems, personal communication products such as cell phones and personal digital assistants, consumer products such as televisions, videogame systems, digital cameras and automobile electronics, and for power management in portable and automotive electronics. The Company also sells hardware and software support and maintenance services for its test systems. The Company is headquartered, and has development and manufacturing facilities, in Westwood, Massachusetts, a development facility in San Jose, California, and worldwide sales and service facilities to support its customer base.

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The accompanying unaudited consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and, accordingly, these footnotes condense or omit information and disclosures which substantially duplicate information provided in our latest audited financial statements. These financial statements should be read in conjunction with the financial statements and notes included in our Annual Report on Form 10-K for the year ended July 31, 2004. In the opinion of our management, these financial statements reflect all adjustments, including normal recurring accruals, necessary for a fair presentation of the results for the interim periods presented. The operating results for the three months ended October 31, 2004 are not necessarily indicative of future trends or our results of operations for the entire year.

 

Revenue Recognition

 

The Company recognizes revenue based on guidance provided in SEC Staff Accounting Bulletin No. 101 (SAB 101), “Revenue Recognition in Financial Statements” and SAB 104, “Revenue Recognition”. In December 2003, the SEC issued SAB 104, “Revenue Recognition”, which codifies, revises and rescinds certain sections of SAB 101. The Company recognizes revenue when persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the seller’s price is fixed or determinable and collectibility is reasonably assured.

 

Revenue related to equipment sales is recognized when: (a) we have a written sales agreement; (b) delivery has occurred or services rendered; (c) the price is fixed or determinable; (d) collectibility is reasonably assured; (e) the product delivered is standard product with historically demonstrated acceptance; and (f) there is no unique customer acceptance provision or payment tied to acceptance or an undelivered element significant to the functionality of the system. Generally, payment terms are net 30 days from shipment. Certain sales include payment terms tied to customer acceptance. If a portion of the payment is linked to product acceptance, which is 20% or less, the revenue is deferred on only the percentage holdback until payment is received or written evidence of acceptance is delivered to the Company. If the portion of the holdback is greater than 20%, the full value of the equipment is deferred until payment is received or written evidence of acceptance is delivered to the Company. When sales to a customer involve multiple elements, revenue is recognized on the delivered element provided that (1) the undelivered element is a standard product, (2) there is a history of acceptance on the product with the customer, and (3) the undelivered element is not essential to the customer’s application. Revenue related to spare parts is recognized on shipment. Revenue related to maintenance and service contracts is recognized ratably over the duration of the contracts.

 

Engineering and Product Development Costs

 

The Company expenses all engineering, research and development costs as incurred. Expenses subject to capitalization in accordance with the Statement of Financial Accounting Standards (SFAS) No. 86, “Accounting for the Costs of Computer Software To Be Sold, Leased or Otherwise Marketed”, relating to certain software development costs, were insignificant.

 

6


Table of Contents

Shipping and Handling Costs

 

Shipping and handling costs are included in cost of sales in the consolidated statements of income. These costs, when included in the sales price charged for products, are recognized in net sales. Shipping and handling costs were insignificant for the three months ended October 31, 2004 and 2003.

 

Income Taxes

 

In accordance with SFAS No. 109, “Accounting for Income Taxes”, the Company recognizes deferred income taxes based on the expected future tax consequences of differences between the financial statement bases and the tax bases of assets and liabilities, calculated using enacted tax rates for the year in which the differences are expected to be reflected in the tax return. Research and development tax credits are recognized for financial reporting purposes to the extent that they can be used to reduce the tax provision.

 

Accounting for Stock-Based Compensation

 

The Company, as permitted by SFAS No. 123, “Accounting for Stock-Based Compensation”, as amended by SFAS No. 148 “Accounting for Stock-Based Compensation Transition and Disclosure” has elected to continue to apply the provisions of APB Opinion No. 25, “Accounting for Stock Issued to Employees”, and related interpretations in accounting for its employee stock option and stock purchase plans. No stock-based employee compensation is reflected in net income (loss), as all options granted under those plans had an exercise price equal to the market value of the underlying common stock on the date of grant.

 

The following table illustrates the effect on net income and earnings per share as if the Company had applied the fair value recognition provisions of SFAS No. 123 to stock-based employee compensation:

 

    

Three months ended

October 31,


 
     2004

    2003

 
     (in thousands, except per share data)  

Net loss:

                

As reported

   $ (61,673 )   $ (9,806 )

Deduct: Total stock-based employee compensation expense determined under fair value based method for all awards, net of related tax effects

     8,790       12,417  
    


 


Pro forma

   $ (70,463 )   $ (22,223 )
    


 


Net loss per share:

                

Basic

                

As reported

   $ (1.01 )   $ (0.19 )

Pro forma

   $ (1.16 )   $ (0.43 )

Diluted

                

As reported

   $ (1.01 )   $ (0.19 )

Pro forma

   $ (1.16 )   $ (0.43 )

 

The fair value of each option grant is estimated on the grant date using the Black-Scholes option-pricing model with the following weighted average assumptions:

 

     Three months ended
October 31,


 
     2004

    2003

 

Volatility

   88 %   88 %

Dividend yield

   0 %   0 %

Risk-free interest rate

   4.20 %   4.33 %

Expected life of options

   8.68 years     9.11 years  

 

Impairment of Long-Lived Assets Other Than Goodwill

 

On an on-going basis, management reviews the value and period of amortization or depreciation of long-lived assets. In accordance with SFAS No.144, “Accounting for Impairment or Disposal of Long-Lived Assets”, the Company reviews whether impairment losses exist on long-lived assets when indicators of impairment are present. During this review, the Company reevaluates the

 

7


Table of Contents

significant assumptions used in determining the original cost of long-lived assets. Although the assumptions may vary, they generally include revenue growth, operating results, cash flows and other indicators of value. Management then determines whether there has been a permanent impairment of the value of long-lived assets based upon events or circumstances that have occurred since acquisition. The extent of the impairment amount recognized is based upon a determination of the impaired asset’s fair value.

 

Product Warranty Costs

 

Our products are sold with warranty provisions that require us to remedy deficiencies in quality or performance of our products over a specified period of time at no cost to our customers. Our policy is to establish warranty reserves at levels that represent our estimate of the costs that will be incurred to fulfill those warranty requirements at the time that revenue is recognized.

 

The following table shows the change in the product warranty liability, as required by FASB Interpretation No. (FIN) 45, “Guarantor’s Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness of Others”, for the three months ended October 31, 2004 and 2003:

 

     Three Months Ended
October 31,


 

Product Warranty Activity


   2004

    2003

 
     (in thousands)  

Balance at beginning of period

   $ 4,394     $ 1,935  

Warranty expenditures for current period

     (1,885 )     (1,092 )

Changes in liability related to pre-existing warranties

     (306 )     —    

Provision for warranty costs in the period

     1,543       1,598  
    


 


Balance at end of period

   $ 3,746     $ 2,441  
    


 


 

Comprehensive Income

 

Comprehensive income is comprised of two components, net income and other comprehensive income. Other comprehensive income consists of unrealized gains and losses on the Company’s marketable securities.

 

Net Loss per Share

 

Basic net loss per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding for the period. Diluted net loss per share reflects the maximum dilution that would have resulted from the assumed exercise and share repurchase related to dilutive stock options and is computed by dividing net loss by the weighted average number of common shares and all dilutive securities outstanding.

 

8


Table of Contents

Reconciliation between basic and diluted earnings per share is as follows:

 

     Three Months Ended
October 31,


 
     2004

    2003

 
     (in thousands, except per share data)  

Net loss

   $ (61,673 )   $ (9,806 )

Basic EPS

                

Basic common shares

     60,987       51,797  

Basic EPS

   $ (1.01 )   $ (0.19 )

Diluted EPS

                

Basic common shares

     60,987       51,797  

Plus: Impact of stock options

     —         —    
    


 


Diluted common shares

     60,987       51,797  

Diluted EPS

   $ (1.01 )   $ (0.19 )

 

At October 31, 2004 and 2003, options to purchase 7,645,711 shares and 4,198,078 shares of common stock, respectively, were not included in the calculation of diluted net loss per share because their inclusion would have been anti-dilutive. These options could be dilutive in the future.

 

Cash and Cash Equivalents and Marketable Securities

 

The Company considers all highly liquid investments that are readily convertible to cash and that have original maturity dates of three months or less to be cash equivalents. Investments with remaining maturities greater than three months and that mature within one year from the balance sheet date are considered to be marketable securities. Cash and cash equivalents consist primarily of repurchase agreements, commercial paper and money market funds. Marketable securities consist primarily of debt securities that are classified as available-for-sale and are reported at fair value in accordance with SFAS No. 115, “Accounting for Certain Investments in Debt and Equity Securities”. Securities available for sale include corporate and governmental obligations with various contractual maturity dates. Governmental obligations include U.S. Government, State, Municipal and Federal Agency securities.

 

Gross unrealized gains and losses for the three months ended October 31, 2004 and October 31, 2003 were not significant. The realized profits, losses and interest are included in investment income in the Statements of Operations. Unrealized gains and losses are reflected as a separate component of comprehensive income and are included in Stockholders’ Equity.

 

At October 31, 2004, cash balances of approximately $1.5 million were restricted from withdrawal. These funds primarily served as collateral supporting certain operating equipment leases.

 

Inventories

 

Inventories are stated at the lower of cost or market, determined on the first-in, first-out method, and include materials, labor and manufacturing overhead. Inventories consisted of the following at:

 

    

October 31,

2004


  

July 31,

2004


     (in thousands)

Raw materials

   $ 25,956    $ 28,088

Work-in-progress

     5,281      11,787

Finished goods

     9,317      29,345
    

  

     $ 40,554    $ 69,220
    

  

 

Our policy is to establish inventory reserves when conditions exist that suggest our inventory may be in excess of anticipated demand or is obsolete based upon our assumptions about future demand of our products or market conditions. We regularly evaluate the ability to realize the value of our inventory based on a combination of factors including the following: forecasted sales or usage, estimated product end of life dates, estimated current and future market value and new product introductions. Purchasing and alternative usage options are also explored to mitigate inventory exposure. When recorded, our reserves are intended to reduce the carrying value of our inventory to its net realizable value. Pursuant to SAB Topic 5-BB, inventory reserves establish a new cost basis for inventory. Such reserves are not reversed until the related inventory is sold or otherwise disposed of. During the quarter ended October 31, 2004, there were no reversals of reserves related to the sale of previously written down items. As of October 31, 2004, our inventory of $40.6

 

9


Table of Contents

million is stated net of inventory reserves of $129.3 million and consists of second generation Fusion products and engineering materials and less than $5 million of legacy Fusion-HF related spares to support the installed base. Of the $26.0 million comprising the raw materials inventory, $7 million consists of “last time buy” custom components for Fusion HFi and $19 million consists of raw materials for Fusion HFi and CX, which the Company believes will be consumed over the next 12 months. If actual demand for our products deteriorates or market conditions are less favorable than those that we project, additional inventory reserves may be required.

 

Property and Equipment

 

Property and equipment are summarized as follows:

 

(in thousands)

 

  

October 31,

2004


   

July 31,

2004


   

Depreciable Life

In Years


Machinery, equipment and internal manufactured systems

   $ 164,832     $ 161,922     3-7

Office furniture and equipment

     7,692       7,634     3-7

Leasehold improvements

     11,890       11,876     10 or term of lease
    


 


   
       184,414       181,432      

Less: Accumulated depreciation and amortization

     (111,654 )     (110,103 )    
    


 


   
     $ 72,760     $ 71,329      
    


 


   

 

At October 31, 2004 and July 31, 2004, included in machinery and equipment is equipment acquired under capital leases of $3.3 million and $5.7 million respectively. Accumulated amortization related to those assets was $1.4 million and $1.3 million at October 31, 2004 and July 31, 2004, respectively.

 

Goodwill and Other Intangibles

 

The Company has adopted the provisions of Statement No. 142, “Goodwill and Other Intangible Assets”, which requires that goodwill and intangible assets with indefinite useful lives are not amortized. Intangible assets with a definitive useful life are amortized over their estimated useful life. Assets recorded in these categories are tested for impairment at least annually or when a change in circumstances may result in future impairment. Intangible assets are recorded at historical cost. Intangible assets acquired in an acquisition, including purchased research and development, are recorded under the purchase method of accounting. Assets acquired in an acquisition are recorded at their estimated fair values at the date of acquisition. Management uses a discounted cash flow analysis which requires that certain assumptions and estimates be made regarding industry economic factors and future profitability of the acquired business to assess the need for an impairment charge. If the carrying value of the asset is in excess of the present value of the expected future cash flows, the carrying value is written down to fair value in the period identified.

 

Goodwill totaling $13.7 million at each of October 31, 2004 and July 31, 2004, represents the excess of acquisition costs over the estimated fair value of the net assets acquired from StepTech, Inc. on June 10, 2003.

 

Other intangible assets consisted of core technology and amounted to the following at October 31, 2004 and July 31, 2004:

 

Core Technology

(In thousands)


  

Gross

Intangible


  

Accumulated

Amortization


  

Net

Intangible Asset


  

Estimated

Useful Life


October 31, 2004

   $ 2,800    $ 875    $ 1,925    4 years

July 31, 2004

   $ 2,800    $ 700    $ 2,100    4 years

 

Amortization expense for each of the three months ended October 31, 2004 and 2003 was $175,000. The estimated aggregate amortization expense for the remainder of fiscal 2005 is $525,000 and for each of the two succeeding fiscal years is $700,000.

 

3. SEGMENT REPORTING

 

The Company operates predominantly in one industry segment: the design, manufacture and marketing of automatic test equipment for the semiconductor industry that is used to test system-on-a-chip, digital, analog and mixed signal integrated circuits.

 

10


Table of Contents

The Company’s net sales for the three months ended October 31, 2004 and 2003, along with the long-lived assets at October 31, 2004 and July 31, 2004, are summarized as follows:

 

     Three Months Ended
October 31,


     2004

   2003

     (in thousands)

Net Sales:

             

United States

   $ 9,478    $ 8,540

Singapore

     21,842      29,776

Taiwan

     3,319      1,143

Japan

     2,737      3,910

All other countries

     5,657      3,250
    

  

Total Net Sales

   $ 43,033    $ 46,619
    

  

 

    

October 31,

2004


  

July 31

2004


     (in thousands)

Long-lived Assets:

             

United States

   $ 64,436    $ 62,685

Singapore

     4,129      4,410

Taiwan

     1,654      1,502

Japan

     18      19

All other countries

     2,523      2,713
    

  

Total Net Sales

   $ 72,760    $ 71,329
    

  

 

Transfer prices on products sold to foreign subsidiaries are intended to produce profit margins that correspond to the subsidiary’s sales and support efforts.

 

4. REORGANIZATION CHARGES AND INVENTORY PROVISIONS

 

For the quarter ended October 31, 2004, the Company recorded a reorganization charge of approximately $3.1 million, of which $1.5 million consisted of severance costs relating to a worldwide workforce reduction and $1.6 million related to consolidation of the Company’s facilities in the United Kingdom. The $1.6 million non-cash reorganization charge related to the consolidation of the Company’s facilities in the United Kingdom consisted of future lease obligations net of any rental income. As previously disclosed in a current report on Form 8-K filed on September 20, 2004, the workforce reduction undertaken during the quarter eliminated 74 positions, or approximately 11% of the Company’s worldwide workforce and as a result the Company will realize an annual savings in operating expenses of approximately $8.0 million, which will be offset by approximately $2 million as a result of the removal of the salary and wage freeze imposed since 2001. The net effect of the cost reduction actions and the removal of the salary and wage freeze is an annual savings of approximately $6.0 million in operating expenses. During the first quarter of fiscal 2005, the Company’s cash expenditures related to the charges were approximately $0.7 million. At October 31, 2004, the remaining reserve was approximately $2.4 million, which consisted of $0.8 million for severance and $1.6 million for the consolidation of the Company’s facilities in the United Kingdom. The remaining severance costs from the workforce reduction will be paid during fiscal year 2005.

 

The Company reviews excess and obsolete inventory when conditions exist that suggest our inventory may be in excess of anticipated demand or is obsolete based upon our assumptions about future demand for our products or market conditions. We also evaluate our excess and obsolete inventory on a quarterly basis identifying and addressing significant events that might have an impact on inventories and related reserves. The major variables impacting inventory usage are the demand for current products, overall industry conditions, key sales initiatives and the impact that our new product introductions have on current product demand. The longer the duration of the depressed industry conditions, the greater the chance for impairment of our current products due to market and product transitions. See Note 2 of the Notes to Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the fiscal year ended July 31, 2004 under the heading “Inventories” for further discussion of the Company’s reserve policy. During the quarter ended October 31, 2004, the Company recorded a $47.5 million excess and obsolete inventory provision. Of the $47.5 million reserve charged in the quarter, approximately 90% was related to first generation Fusion and consisted of raw materials, work-in-process and finished goods. The remaining 10% was related to excess second generation Fusion products and was made to more accurately reflect the Company’s assessment of current product demand.

 

11


Table of Contents

Inventory reserves establish a new cost basis for inventory and such reserves are not reversed until the related inventory is sold or otherwise disposed of. As of October 31, 2004, our inventory of $40.6 million is net of inventory reserves of $129.3million and consists of second generation Fusion products and engineering materials, and less than $5 million of legacy Fusion HF related spares to support the installed base.

 

5. CONTINGENCIES AND GUARANTEES

 

In the ordinary course of business, we agree from time to time to indemnify certain customers against certain third party claims for property damage, bodily injury, personal injury or intellectual property infringement arising from the operation or use of our products. Also, from time to time in agreements with our suppliers, licensors and other business partners, we agree to indemnify these partners against certain liabilities arising out of the sale or use of our products. The maximum potential amount of future payments we could be required to make under these indemnification obligations is theoretically unlimited; however, we have general and umbrella insurance policies that enable us to recover a portion of any amounts paid and many of our agreements contain a limit on the maximum amount, as well as limits on the types of damages recoverable. Based on our experience with such indemnification claims, we believe the estimated fair value of these obligations is minimal. Accordingly, we have no liabilities recorded for these agreements as of October 31, 2004 or July 31, 2004.

 

Subject to certain limitations, LTX indemnifies its current and former officers and directors for certain events or occurrences. Although the maximum potential amount of future payments LTX could be required to make under these agreements is theoretically unlimited, as there were no known or pending claims, we have not accrued a liability for these agreements as of October 31, 2004 or July 31, 2004.

 

The Company has operating lease commitments for certain facilities and equipment and capital lease commitments for certain equipment. Minimum lease payments under noncancelable leases at October 31, 2004, are as follows:

 

Year ended July 31,


   (in thousands)
Amount


2005

   $ 7,793

2006

     9,560

2007

     6,609

2008

     3,121

2009

     2,033

Thereafter

     307
    

Total minimum lease payments

   $ 29,423
    

 

Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Industry Conditions and Outlook

 

We sell capital equipment and services to companies that design, manufacture, assemble or test semiconductor devices. The semiconductor industry is highly cyclical, causing in turn a cyclical impact on our financial results. As a capital equipment provider, our revenue is driven by the capital expenditure budgets and spending patterns of our customers, who often delay or accelerate purchases in reaction to variations in their business. The level of capital expenditures by these semiconductor companies depends on the current and anticipated market demand for semiconductor devices and the products that incorporate them. Therefore, demand for our semiconductor test equipment is dependent on growth in the semiconductor industry. In particular, three primary characteristics of the semiconductor industry drive the demand for semiconductor test equipment:

 

  increases in volume of unit production of semiconductor devices;

 

  increases in the complexity of semiconductor devices used in electronic products; and

 

  the emergence of next generation device technologies, such as SOC.

 

The semiconductor industry is highly cyclical, causing in turn a cyclical impact on our financial results. Our operating results were negatively impacted by a severe industry-wide slowdown in the semiconductor industry, which began to affect the semiconductor test industry in fiscal 2001 and continued through our fiscal year ended July 31, 2003. However the industry entered a period of growth during our fiscal year ended July 31, 2004 and the Company’s quarterly revenues increased sequentially each quarter during the fiscal year. The period of growth was short and we experienced a sharp decline in orders in the first quarter of fiscal year 2005. We believe

 

12


Table of Contents

we are in another industry-wide slowdown. The Company’s results of operations would be further adversely affected if we were to experience lower than anticipated order levels, cancellations of orders in backlog, extended customer delivery requirements or pricing pressure as a result of this slowdown. At lower levels of revenue, there is a higher likelihood that these types of changes in our customers’ requirements would adversely affect our results of operations because in any particular quarter a limited number of transactions accounts for an even greater portion of sales for the quarter.

 

Consistent with our business strategy, we have continued to invest significant amounts in engineering and product development to develop and enhance our Fusion platform during slowdowns. We believe that our competitive advantage in the semiconductor test industry is primarily driven by the ability of our Fusion platform to meet or exceed the highest technical specifications required for the testing of the most advanced semiconductor devices in a cost-efficient manner. We believe this will continue to differentiate the Fusion platform from the product offerings of our competitors.

 

We are also exposed to the risks associated with the current emerging recovery in the U.S. and global economies. The lack of visibility regarding whether or when there will be a sustained recovery in the sale of electronic goods and information technology equipment, and uncertainty regarding the magnitude of the recovery, underscores the need for caution in predicting growth in the semiconductor test equipment industry in general and in our revenues and profits specifically. Slow or negative growth in the domestic economy may continue to materially and adversely affect our business, financial condition and results of operations for the foreseeable future.

 

Critical Accounting Policies and the Use of Estimates

 

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amount of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. We base these estimates and assumptions on historical experience, and evaluate them on an on-going basis to ensure they remain reasonable under current conditions. Actual results could differ from those estimates. We discuss the development and selection of the critical accounting estimates with the audit committee of our board of directors on a quarterly basis, and the audit committee has reviewed the Company’s critical accounting estimates as described in Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in the Company’s Annual Report on Form 10-K for the fiscal year ended July 31, 2004. For the three months ended October 31, 2004, there have been no changes to these critical accounting policies.

 

Results of Operations

 

The following table sets forth for the periods indicated the principal items included in the Consolidated Statement of Operations as percentages of net sales.

 

     Percentage of Net Sales

 
    

Three Months Ended

October 31,


 
     2004

    2003

 

Net Sales

   100.0 %   100.0 %

Cost of Sales

   65.6     69.8  

Inventory related provision

   110.3     —    
    

 

Gross profit (loss)

   (75.9 )   30.2  

Engineering and product development expenses

   41.0     35.5  

Selling, general and administrative expenses

   18.3     13.7  

Reorganization costs

   7.2     —    
    

 

Loss from operations

   (142.4 )   (19.0 )

Other income (expense):

            

Interest expense

   (3.9 )   (3.7 )

Investment income

   3.0     1.7  
    

 

Net loss

   (143.3 )%   (21.0 )%
    

 

 

The discussion below contains certain forward-looking statements relating to, among other things, estimates of economic and industry conditions, sales trends, expense levels and capital expenditures. Actual results may vary from those contained in such forward-looking statements. See “Business Risks” below.

 

Three Months Ended October 31, 2004 Compared to the Three Months Ended October 31, 2003.

 

Net sales. Net sales consist of both semiconductor test equipment and related hardware and software support and maintenance services, net of returns and allowances. Net sales for the three months ended October 31, 2004 decreased 7.7% to $43.0 million as

 

13


Table of Contents

compared to $46.6 million in the same quarter of the prior year. Net sales also decreased quarter over quarter, decreasing by 46.5% or $37.4 million, from the fourth quarter of fiscal year 2004. The decrease in net sales is primarily a result of sluggish demand for semiconductors resulting in reduced demand for semiconductor test equipment. Our sales orders began to decline in the fourth quarter of fiscal year 2004 and have continued to remain at low levels in the first quarter of fiscal year 2005. Service revenue accounted for $8.3 million, or 19.3% of net sales, and $9.1 million, or 19.5% of net sales, for the three months ended October 31, 2004 and 2003, respectively. Geographically, sales to customers outside of the United States were 78.0% and 81.7% of net sales for the three months ended October 31, 2004 and October 31, 2003, respectively.

 

Gross Profit Margin; Inventory Related Provision. The gross profit margin was 34.4% of net sales in the three months ended October 31, 2004 (excluding the $47.5 million inventory related provision), as compared to 30.2% of net sales in the same quarter of the prior year. The increase in gross profit margin is primarily a result of changes in product mix as the Company transitions to its second generation products, which have higher profit margins.

 

The Company reviews excess and obsolete inventory when conditions exist that suggest our inventory may be in excess of anticipated demand or is obsolete based upon our assumptions about future demand for our products or market conditions. We also evaluate our excess and obsolete inventory on a quarterly basis identifying and addressing significant events that might have an impact on inventories and related reserves. The major variables impacting inventory usage are the demand for current products, overall industry conditions, key sales initiatives and the impact that our new product introductions have on current product demand. The longer the duration of the depressed industry conditions, the greater the chance for impairment of our current products due to market and product transitions. See Note 2 of the Notes to Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the fiscal year ended July 31, 2004 under the heading “Inventories” for further discussion of the Company’s reserve policy. The impact to the Company of any industry slowdown is exacerbated by the fact that the semiconductor industry is highly concentrated, and a small number of device manufacturers and contract assemblers account for a substantial portion of the purchases of semiconductor test equipment, including the Company’s equipment. Sales to our ten largest customers accounted for 89.2% of revenues for the three months ended October 31, 2004 and 92.7% for the three months ended October 31, 2003, and, therefore, reduced sales from any one of our customers could have a significant affect on our sales. In the first quarter of fiscal 2005, our major customers reduced their forecasts for capital equipment purchases, which resulted in a sudden and substantial drop in revenues and orders for the Company. As a result of the shorter than expected upturn in business conditions in fiscal 2004, and the completion of the Company’s transition to its second generation Fusion, we deemed it appropriate to make an adjustment to our inventory and recorded a $47.5 million excess and obsolete inventory provision. Of the $47.5 million reserve, approximately 90% was related to first generation Fusion and consisted of raw materials, work-in-process and finished goods. The remaining 10% was related to excess second generation Fusion products and was made to more accurately reflect the Company’s assessment of current product demand.

 

Inventory reserves establish a new cost basis for inventory and such reserves are not reversed until the related inventory is sold or otherwise disposed of. As of October 31, 2004, our inventory of $40.6 million is net of inventory reserves of $129.3million and consists of second generation Fusion products and engineering materials, and less than $5 million of legacy Fusion HF related spares to support the installed base.

 

Engineering and Product Development Expenses. Engineering and product development expenses were $17.6 million, or 41.0% of net sales, in the three months ended October 31, 2004, as compared to $16.6 million, or 35.5% of net sales, in the same quarter of the prior year. The $1.0 million increase in engineering and product development expenses for the three months ended October 31, 2004 as compared to October 31, 2003 is principally a result of an increase in non-recurring engineering charges to support new applications related to new product sale initiatives. Consistent with the Company’s strategy of extending our technological lead in single platform testing during an industry downturn, we continue to maintain a significant investment in product development expenses to support new product features and emerging applications.

 

Selling, General and Administrative Expenses. Selling, general and administrative expenses were $7.9 million, or 18.3% of net sales, in the three months ended October 31, 2004, as compared to $6.4 million, or 13.7% of net sales, in the same quarter of the prior year, an increase of $1.5 million, or a 4.6% increase in the expense as a percentage of net sales. The increase in selling, general and administrative expenses for the three months ended October 31, 2004 was a result of an increase of 11 employees in our sales and marketing staff to support new products and marketing programs, higher commission expense due to product mix incentives and increased travel expenses to support new account wins.

 

Reorganization Costs. For the quarter ended October 31, 2004, the Company recorded a reorganization charge of approximately $3.1 million, of which $1.5 million consisted of severance costs relating to a worldwide workforce reduction and $1.6 related to consolidation of the Company’s facilities in the United Kingdom. The $1.6 million non-cash reorganization charge related to the consolidation of the Company’s facilities in the United Kingdom consisted of future lease obligations net any rental income. As previously disclosed in a current report on Form 8-K filed on September 20, 2004, the workforce reduction undertaken during the quarter eliminated 74 positions, or approximately 11% of the Company’s worldwide workforce. As a result of these actions, the Company will realize an annual savings in operating expenses of approximately $8.0 million, which will be offset by approximately

 

14


Table of Contents

$2 million as a result of the removal of the salary and wage freeze imposed since 2001. The net effect of the cost reduction actions and the removal of the salary and wage freeze is an annual savings of approximately $6.0 million in operating expenses. During the first quarter of fiscal 2005, the Company’s cash expenditures related to the charges were approximately $0.7 million. At October 31, 2004, the remaining reserve was approximately $2.4 million, which consisted of $0.8 million for severance and $1.6 million for the consolidation of the Company’s facilities in the United Kingdom. The remaining severance costs from the workforce reduction will be paid during fiscal year 2005.

 

Interest Expense. Interest expense was $1.7 million for each of the three months ended October 31, 2004 and October 31, 2003. Approximately $1.6 million of accrued expense for each of the three months ended October 31, 2004 and October 31, 2003 is the accrued interest expense for the 4.25% convertible subordinated notes.

 

Investment Income. Investment income was $1.3 million for the three months ended October 31, 2004, as compared to $0.8 million for the three months ended October 31, 2003. Investment income was higher in the three months ended October 31, 2004 than the same period of the prior year as a result of higher average cash and cash equivalents and marketable securities balances and improving interest rates.

 

Income Tax. For the three months ended October 31, 2004, the Company recorded no income tax benefit due to the uncertainty related to utilization of net operating loss carryforwards. As a result of a review undertaken at October 31, 2004 and our cumulative loss position at that date, management concluded that it was appropriate to maintain a full valuation allowance for its operating loss carryforwards and its other net deferred tax assets. The Company recorded a $24.7 million tax benefit for the quarter ended October 31, 2004.

 

Net Loss. Net loss was $61.7 million, or $1.01 per diluted share, in the three months ended October 31, 2004, as compared to a net loss of $9.8 million, or $0.19 per diluted share, in the same quarter of the prior year.

 

Liquidity and Capital Resources

 

At October 31, 2004, the Company had $206.3 million in cash and cash equivalents and marketable securities and working capital of $230.7 million, as compared to $244.7 million of cash and cash equivalents and marketable securities and $292.9 million of working capital at July 31, 2004. The decrease in the cash and cash equivalents and marketable securities was due primarily to cash used in operations of $33.4 million and cash used in capital purchases of $4.9 million. Cash used in operations consisted of a $26.2 million increase in working capital related to purchases of materials to support a higher level of sales and a $7.2 million loss before depreciation, excluding the inventory related provision and reorganization charge.

 

Accounts receivable from trade customers was $26.0 million at October 31, 2004, as compared to $33.0 million at July 31, 2004. The principal reason for the $7.0 million decrease in accounts receivable is a result of decreased sales. The allowance for sales returns and doubtful accounts was $2.0 million, or 7.2% of gross trade accounts receivable, at October 31, 2004 and $2.0 million, or 5.8% of gross trade accounts receivable at July 31, 2004. Accounts receivable from other sources decreased $4.0 million to $7.5 million at October 31, 2004, as compared to $11.5 million at July 31, 2004. The decrease was attributed to the decrease in the sale of component inventory at cost to our outsource suppliers.

 

Net inventories decreased by $28.6 million to $40.6 million at October 31, 2004 as compared to $69.2 million at July 31, 2004. The decrease was primarily the result of an inventory related provision of $47.5 million recorded in our first quarter ended October 31, 2004. Offsetting the charge of $47.5 million to the excess reserve was an increase in inventories to support Fusion HFi and CX of $18.9 million. Of the $18.9 million, $1.8 million consisted of deposits previously made to suppliers of critical components to ensure delivery and $17.1 million consisted of new inventory purchases. The $18.9 million increase in inventory was a result of the sudden and substantial drop in revenue in the first quarter of fiscal 2005 compared to revenue in the fourth quarter of fiscal year 2004, which created an excess of Fusion HFi and Fusion CX inventories. The Company expects to consume this inventory within the next 12 months.

 

Prepaid expense decreased by $2.4 million to $7.4 million at October 31, 2004 as compared to $9.8 million at July 31, 2004. The decrease was attributed to the receipt of inventory against prepayments and amortization of prepaid insurance premiums and maintenance contract prepayments, which amounted to $0.5 million. Inventory related deposits were $0.2 million at October 31, 2004 and $2.0 million at July 31, 2004.

 

Capital expenditures totaled $4.9 million for the three months ended October 31, 2004, as compared to $4.0 million for the three months ended October 31, 2003. The principal reason for the $0.9 million increase in expenditures is attributed to the purchase of additional capital equipment to support increased applications development, and increased levels of spare parts to support our two new products, Fusion HFi and Fusion CX.

 

During the quarter ended October 31, 2003, we renegotiated our domestic credit facility with our existing lender. The facility is comprised of a working capital line of $30.0 million, which is secured by all assets and bears interest at the bank’s prime rate. The

 

15


Table of Contents

working capital line is used to support working capital obligations, issuance of standby letters of credit, and foreign exchange transactions and to support the purchase of fixed assets. The facility imposes certain financial and other covenants. This credit facility expired on November 15, 2004. The Company has a second credit facility with another lender for a revolving credit line of $20.0 million. This facility is secured by cash and bears interest (at our option) at either: (i) the greater of the federal funds rate plus 0.5% or the bank’s prime rate, in each case, minus 1.0% or (ii) LIBOR plus 0.4%. This facility expires on July 23, 2005. No amounts were outstanding under these credit facilities at October 31, 2004.

 

In January 2004, we filed a shelf registration statement on Form S-3 to register up to $250 million of common stock, debt securities and warrants. On February 19, 2004, we closed an offering made pursuant to the registration statement relating to the sale of 8,050,000 shares of our common stock at $16.50 per share. The offering included 1,050,010 shares sold as a result of the exercise, in full, by the underwriters of their option to purchase additional shares of common stock. Gross proceeds from the stock offering totaled approximately $132.8 million. Proceeds to LTX, net of $6.3 million in underwriters’ commissions and discounts and other expenses, totaled approximately $126.5 million.

 

The Company operates in a highly cyclical industry and we may experience, with relatively short notice, significant fluctuations in demand for our products. This could result in a material effect on our liquidity position. To mitigate the risk, we have completed a substantial and lengthy process of converting our manufacturing process to an outsource model. As such, we believe we can react to a downturn or a significant upturn much faster than in the past. We believe that our balances of cash and cash equivalents, cash flows expected to be generated by future operating activities, our ready access to capital markets for competitively priced instruments and funds available under our credit facilities will be sufficient to meet our cash requirements over the next twelve to twenty-four months.

 

Commitments and Contingencies

 

Our major outstanding contractual obligations are related to our convertible subordinated notes, facilities leases and other capital and operating leases. The Company has 4.25% convertible subordinated notes due in 2006. Interest on the notes is payable on February 15 and August 15 of each year, commencing February 15, 2002. The outstanding principal of the notes was $150.0 million as of October 31, 2004.

 

The aggregate outstanding amount of the contractual obligations is $192.3 million as of October 31, 2004. These obligations and commitments represent maximum payments based on current operating forecasts. Certain of the commitments could be reduced if changes to our operating forecasts occur in the future.

 

The following summarizes LTX’s contractual obligations, net of sub-lease revenue, at October 31, 2004 and the effect such obligations are expected to have on its liquidity and cash flow in the future periods:

 

     Payments Due by Period (in thousands)

Financial Obligations


   Total

   Remainder
of 2005


   2006 –2007

   2008 –2009

   Thereafter

Convertible Subordinated Notes

   $ 162,750    $ 6,375    $ 156,375    $ —      $  —  

Operating Leases

     29,423      7,793      16,169      5,154      307

Capital Leases

     169      169      —        —        —  
    

  

  

  

  

Total Contractual Obligations

   $ 192,342    $ 14,337    $ 172,544    $ 5,154    $ 307
    

  

  

  

  

 

BUSINESS RISKS

 

This report includes or incorporates forward-looking statements that involve substantial risks and uncertainties and fall within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. You can identify these forward-looking statements by our use of the words “believes,” “anticipates,” “plans,” “expects,” “may,” “will,” “would,” “intends,” “estimates,” and similar expressions, whether in the negative or affirmative. We cannot guarantee that we actually will achieve these plans, intentions or expectations. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements we make. We have included important factors in the cautionary statements, particularly under the heading “Business Risks,” that we believe could cause our actual results to differ materially from the forward-looking statements that we make. We do not assume any obligation to update any forward-looking statement we make.

 

Our sole market is the highly cyclical semiconductor industry, which causes a cyclical impact on our financial results.

 

We sell capital equipment to companies that design, manufacture, assemble, and test semiconductor devices. The semiconductor industry is highly cyclical, causing in turn a cyclical impact on our financial results. Our recent operating results have been negatively impacted by an industry-wide slowdown in the semiconductor industry which began to impact us in the latter half of the fourth quarter of fiscal 2004. Any failure to expand in cycle upturns to meet customer demand and delivery requirements or contract in cycle downturns at a pace consistent with cycles in the industry could have an adverse effect on our business.

 

16


Table of Contents

Any significant downturn in the markets for our customers’ semiconductor devices or in general economic conditions would likely result in a reduction in demand for our products and would hurt our business. From the third quarter of fiscal 2001 through the end of the first quarter of fiscal 2004, our revenue and operating results were negatively impacted by a sudden and severe downturn in the semiconductor industry. Downturns in the semiconductor test equipment industry have been characterized by diminished product demand, excess production capacity, accelerated erosion of selling prices and excessive inventory levels. We believe the markets for newer generations of devices, including system-on-a-chip (“SOC”), will also experience similar characteristics. Our market is also characterized by rapid technological change and changes in customer demand. In the past, we have experienced delays in commitments, delays in collecting accounts receivable and significant declines in demand for our products during these downturns, and we cannot be certain that we will be able to maintain or exceed our current level of sales.

 

Additionally, as a capital equipment provider, our revenue is driven by the capital expenditure budgets and spending patterns of our customers who often delay or accelerate purchases in reaction to variations in their businesses. Because a high proportion of our costs are fixed, we are limited in our ability to reduce expenses and inventory purchases quickly in response to decreases in orders and revenues. In a contraction, we may not be able to reduce our significant fixed costs, such as continued investment in research and development and capital equipment requirements and materials purchases from our suppliers.

 

The market for semiconductor test equipment is highly concentrated, and we have limited opportunities to sell our products.

 

The semiconductor industry is highly concentrated, and a small number of semiconductor device manufacturers and contract assemblers account for a substantial portion of the purchases of semiconductor test equipment generally, including our test equipment. Sales to Texas Instruments accounted for 58% of our net sales in fiscal 2004 and for 58% of our net sales in fiscal 2003. Sales to our ten largest customers accounted for 89.2% of revenues for the three months ended October 31, 2004 and 92.7% in the same three months for the prior year. Our customers may cancel orders with few or no penalties. If a major customer reduces orders for any reason, our revenues, operating results, and financial condition will be hurt.

 

Our ability to increase our sales will depend in part upon our ability to obtain orders from new customers. Semiconductor manufacturers select a particular vendor’s test system for testing the manufacturer’s new generations of devices and make substantial investments to develop related test program software and interfaces. Once a manufacturer has selected one test system vendor for a generation of devices, that manufacturer is more likely to purchase test systems from that vendor for that generation of devices, and, possibly, subsequent generations of devices as well. Therefore, the opportunities to obtain orders from new customers may be limited.

 

Our sales and operating results have fluctuated significantly from period to period, including from one quarter to another, and they may continue to do so.

 

Our quarterly and annual operating results are affected by a wide variety of factors that could adversely affect sales or profitability or lead to significant variability in our operating results or our stock price. This may be caused by a combination of factors, including the following:

 

  sales of a limited number of test systems account for a substantial portion of our net sales in any particular fiscal quarter, and a small number of transactions could therefore have a significant impact;

 

  order cancellations by customers;

 

  lower gross margins in any particular period due to changes in:

 

  our product mix,

 

  the configurations of test systems sold,

 

  the customers to whom we sell these systems, or

 

  volume.

 

  a long sales cycle, due to the high selling price of our test systems, the significant investment made by our customers, and the time required to incorporate our systems into our customers’ design or manufacturing process; and

 

17


Table of Contents
  changes in the timing of product orders due to:

 

  unexpected delays in the introduction of products by our customers,

 

  shorter than expected lifecycles of our customers’ semiconductor devices,

 

  uncertain market acceptance of products developed by our customers, or

 

  our own research and development.

 

We cannot predict the impact of these and other factors on our sales and operating results in any future period. Results of operations in any period, therefore, should not be considered indicative of the results to be expected for any future period. Because of this difficulty in predicting future performance, our operating results may fall below expectations of securities analysts or investors in some future quarter or quarters. Our failure to meet these expectations would likely adversely affect the market price of our common stock.

 

A substantial amount of the shipments of our test systems for a particular quarter occur late in the quarter. Our shipment pattern exposes us to significant risks in the event of problems during the complex process of final integration, test and acceptance prior to shipment. If we were to experience problems of this type late in our quarter, shipments could be delayed and our operating results could fall below expectations.

 

We depend on Jabil Circuit to produce and test our family of Fusion products, and any failures or other problems at or with Jabil could cause us to lose customers and revenues.

 

We have selected Jabil Circuit, Inc. to manufacture our Fusion test systems. If for any reason Jabil cannot provide us with these products and services in a timely fashion, or at all, whether due to labor shortage, slow down or stoppage, deteriorating financial or business conditions or any other reason, we would not be able to sell or ship our Fusion family of products to our customers. All of the products Jabil tests and assembles for us are assembled in one facility in Massachusetts. If this facility were to become unable to meet our production requirements, transitioning assembly to an alternative Jabil facility could result it production delays of several weeks or more. We have no written supply agreement with Jabil. We also may be unable to engage alternative production and testing services on a timely basis or upon terms favorable to us, if at all. This relationship with Jabil may not result in a reduction of our fixed expenses.

 

We also may be unable to engage alternative production and testing services on a timely basis or upon terms favorable to us, if at all. If we are required for any reason to seek a new manufacturer of our test systems, an alternate manufacturer may not be available and, in any event, transitioning to a new manufacturer would require a significant lead time of six months or more and would involve substantial expense and disruption of our business. Our test systems are highly sophisticated and complex capital equipment, with many custom components, and require specific technical know-how and expertise. These factors could make it more difficult for us to find a new manufacturer of our test systems if our relationship with Jabil is terminated for any reason, which would cause us to lose revenues and customers.

 

Future acquisitions may be difficult to integrate, disrupt our business, dilute stockholder value or divert management attention.

 

We have in the past, and may in the future, seek to acquire or invest in additional complementary businesses, products, technologies or engineers. For example, in June 2003, we completed our acquisition of StepTech, Inc. We may have to issue debt or equity securities to pay for future acquisitions, which could be dilutive to then current stockholders. We have also incurred and may continue to incur certain liabilities or other expenses in connection with acquisitions, which could continue to materially adversely affect our business, financial condition and results of operations.

 

Mergers and acquisitions of high-technology companies are inherently risky, and no assurance can be given that future acquisitions will be successful and will not materially adversely affect our business, operating results or financial condition. Our past and future acquisitions may involve many risks, including:

 

  difficulties in managing our growth following acquisitions;

 

  difficulties in the integration of the acquired personnel, operations, technologies, products and systems of the acquired companies;

 

  uncertainties concerning the intellectual property rights we purport to acquire;

 

  unanticipated costs or liabilities associated with the acquisitions;

 

18


Table of Contents
  diversion of managements’ attention from other business concerns;

 

  adverse effects on our existing business relationships with our or our acquired companies’ customers;

 

  potential difficulties in completing projects associated with purchased in process research and development; and

 

  inability to retain employees of acquired companies.

 

Any of the events described in the foregoing paragraphs could have an adverse effect on our business, financial condition and results of operations and could cause the price of our common stock to decline.

 

Our dependence on subcontractors and sole source suppliers may prevent us from delivering an acceptable product on a timely basis.

 

We rely on subcontractors to manufacture Fusion and many of the components and subassemblies for our products, and we rely on sole source suppliers for certain components. We may be required to qualify new or additional subcontractors and suppliers due to capacity constraints, competitive or quality concerns or other risks that may arise, including a result of a change in control of, or deterioration in the financial condition of, a supplier or subcontractor. The process of qualifying subcontractors and suppliers is a lengthy process. Our reliance on subcontractors gives us less control over the manufacturing process and exposes us to significant risks, especially inadequate capacity, late delivery, substandard quality, and high costs. In addition, the manufacture of certain of these components and subassemblies is an extremely complex process. If a supplier became unable to provide parts in the volumes needed or at an acceptable price, we would have to identify and qualify acceptable replacements from alternative sources of supply, or manufacture such components internally. The failure to qualify acceptable replacements quickly would delay the manufactured deliver of our products, which could cause us to lose revenues and customers.

 

We are dependent on two semiconductor device manufacturers, Vitesse Semiconductor and Maxtech Components. Each is a sole source supplier of components manufactured in accordance with our proprietary design and specifications. We have no written supply agreements with these sole source suppliers and purchase our custom components through individual purchase orders. Vitesse Semiconductor is also a Fusion customer.

 

We may not be able to deliver custom hardware options and software applications to satisfy specific customer needs in a timely manner.

 

We must develop and deliver customized hardware and software to meet our customers’ specific test requirements. Our test equipment may fail to meet our customers’ technical or cost requirements and may be replaced by competitive equipment or an alternative technology solution. Our inability to provide a test system that meets requested performance criteria when required by a device manufacturer would severely damage our reputation with that customer. This loss of reputation may make it substantially more difficult for us to sell test systems to that manufacturer for a number of years. We have, in the past, experienced delays in introducing some of our products and enhancements.

 

Our dependence on international sales and non-U.S. suppliers involves significant risk.

 

International sales have constituted a significant portion of our revenues in recent years, and we expect that this composition will continue. International sales accounted for 78% of our revenues for the three months ended October 31, 2004 and 82% of our revenue for the three months ended October 31, 2003. In addition, we rely on non-U.S. suppliers for several components of the equipment we sell. As a result, a major part of our revenues and the ability to manufacture our products are subject to the risks associated with international commerce. A reduction in revenues or a disruption or increase in the cost of our manufacturing materials could hurt our operating results. These international relationships make us particularly sensitive to changes in the countries from which we derive sales and obtain supplies. International sales and our relationships with suppliers may be hurt by many factors, including:

 

  changes in law or policy resulting in burdensome government controls, tariffs, restrictions, embargoes or export license requirements;

 

  political and economic instability in our target international markets;

 

  longer payment cycles common in foreign markets;

 

  difficulties of staffing and managing our international operations;

 

19


Table of Contents
  less favorable foreign intellectual property laws making it harder to protect our technology from appropriation by competitors; and

 

  difficulties collecting our accounts receivable because of the distance and different legal rules.

 

In the past, we have incurred expenses to meet new regulatory requirements in Europe, experienced periodic difficulties in obtaining timely payment from non-U.S. customers, and been affected by the recession in several Asian countries. Our foreign sales are typically invoiced and collected in U.S. dollars. A strengthening in the dollar relative to the currencies of those countries where we do business would increase the prices of our products as stated in those currencies and could hurt our sales in those countries. Significant fluctuations in the exchange rates between the U.S. dollar and foreign currencies could cause us to lower our prices and thus reduce our profitability. These fluctuations could also cause prospective customers to push out or delay orders because of the increased relative cost of our products. In the past, there have been significant fluctuations in the exchange rates between the dollar and the currencies of countries in which we do business. While we have not entered into significant foreign currency hedging arrangements, we may do so in the future. If we do enter into foreign currency hedging arrangements, they may not be effective.

 

Our market is highly competitive, and we have limited resources to compete.

 

The test equipment industry is highly competitive in all areas of the world. Many other domestic and foreign companies participate in the markets for each of our products, and the industry is highly competitive. Our competitors in the market for semiconductor test equipment include Agilent Technologies, Credence Systems, and Teradyne. These major competitors have substantially greater financial resources and more extensive engineering, manufacturing, marketing, and customer support capabilities.

 

We expect our competitors to enhance their current products and to introduce new products with comparable or better price and performance. The introduction of competing products could hurt sales of our current and future products. In addition, new competitors, including semiconductor manufacturers themselves, may offer new testing technologies, which may in turn reduce the value of our product lines. Increased competition could lead to intensified price-based competition, which would hurt our business and results of operations. Unless we are able to invest significant financial resources in developing products and maintaining customer support centers worldwide, we may not be able to compete effectively.

 

Development of our products requires significant lead-time, and we may fail to correctly anticipate the technical needs of our customers.

 

Our customers make decisions regarding purchases of our test equipment while their devices are still in development. Our test systems are used by our customers to develop, test and manufacture their new devices. We therefore must anticipate industry trends and develop products in advance of the commercialization of our customers’ devices, requiring us to make significant capital investments to develop new test equipment for our customers well before their devices are introduced. If our customers fail to introduce their devices in a timely manner or the market does not accept their devices, we may not recover our capital investment through sales in significant volume. In addition, even if we are able to successfully develop enhancements or new generations of our products, these enhancements or new generations of products may not generate revenue in excess of the costs of development, and they may be quickly rendered obsolete by changing customer preferences or the introduction of products embodying new technologies or features by our competitors. Furthermore, if we were to make announcements of product delays, or if our competitors were to make announcements of new test systems, these announcements could cause our customers to defer or forego purchases of our existing test systems, which would also hurt our business.

 

Our success depends on attracting and retaining key personnel.

 

Our success will depend substantially upon the continued service of our executive officers and key personnel, none of whom are bound by an employment or non-competition agreement. Our success will depend on our ability to attract and retain highly qualified managers and technical, engineering, marketing, sales and support personnel. Competition for such specialized personnel is intense, and it may become more difficult for us to hire or retain them. Our volatile business cycles only aggravate this problem. Our layoffs in any industry downturn could make it more difficult for us to hire or retain qualified personnel. Our business, financial condition and results of operations could be materially adversely affected by the loss of any of our key employees, by the failure of any key employee to perform in his or her current positions, or by our inability to attract and retain skilled employees.

 

We may not be able to protect our intellectual property rights.

 

Our success depends in part on our ability to obtain intellectual property rights and licenses and to preserve other intellectual property rights covering our products and development and testing tools. To that end, we have obtained certain domestic patents and may continue to seek patents on our inventions when appropriate. We have also obtained certain trademark registrations. To date, we have not sought patent protection in any countries other than the United States, which may impair our ability to protect our intellectual property in foreign jurisdictions. The process of seeking intellectual property protection can be time consuming and expensive. We cannot ensure that:

 

  patents will issue from currently pending or future applications;

 

20


Table of Contents
  our existing patents or any new patents will be sufficient in scope or strength to provide meaningful protection or any commercial advantage to us;

 

  foreign intellectual property laws will protect our intellectual property rights; or

 

  others will not independently develop similar products, duplicate our products or design around our technology.

 

If we do not successfully enforce our intellectual property rights, our competitive position could suffer, which could harm our operating results. We also rely on trade secrets, proprietary know-how and confidentiality provisions in agreements with employees and consultants to protect our intellectual property. Other parties may not comply with the terms of their agreements with us, and we may not be able to adequately enforce our rights against these people.

 

Third parties may claim we are infringing their intellectual property, and we could suffer significant litigation costs, licensing expenses or be prevented from selling our products.

 

Intellectual property rights are uncertain and involve complex legal and factual questions. We may be unknowingly infringing on the intellectual property rights of others and may be liable for that infringement, which could result in significant liability for us. If we do infringe the intellectual property rights of others, we could be forced to either seek a license to intellectual property rights of others or alter our products so that they no longer infringe the intellectual property rights of others. A license could be very expensive to obtain or may not be available at all. Similarly, changing our products or processes to avoid infringing the rights of others may be costly or impractical.

 

We are responsible for any patent litigation costs. If we were to become involved in a dispute regarding intellectual property, whether ours or that of another company, we may have to participate in legal proceedings. These types of proceedings may be costly and time consuming for us, even if we eventually prevail. If we do not prevail, we might be forced to pay significant damages, obtain licenses, modify our products or processes, stop making products or stop using processes.

 

Our stock price is volatile.

 

In the twelve-month period ending on October 31, 2004, our stock price ranged from a low of $4.99 to a high of $19.83. The price of our common stock has been and likely will continue to be subject to wide fluctuations in response to a number of events and factors, such as:

 

  quarterly variations in operating results;

 

  variances of our quarterly results of operations from securities analyst estimates;

 

  changes in financial estimates and recommendations by securities analysts;

 

  announcements of technological innovations, new products, or strategic alliances; and

 

  news reports relating to trends in our markets.

 

In addition, the stock market in general, and the market prices for semiconductor-related companies in particular, have experienced significant price and volume fluctuations that often have been unrelated to the operating performance of the companies affected by these fluctuations. These broad market fluctuations may adversely affect the market price of our common stock, regardless of our operating performance.

 

We have substantial indebtedness.

 

We have $150 million principal amount of 4.25% Convertible Subordinated Notes (the “Notes”) due 2006. We may incur substantial additional indebtedness in the future. The level of indebtedness, among other things, could

 

  make it difficult for us to make payments on our debt and other obligations;

 

21


Table of Contents
  make it difficult for us to obtain any necessary future financing for working capital, capital expenditures, debt service requirements or other purposes;

 

  require the dedication of a substantial portion of any cash flow from operations to service for indebtedness, thereby reducing the amount of cash flow available for other purposes, including capital expenditures;

 

  limit our flexibility in planning for, or reacting to changes in, its business and the industries in which we compete;

 

  place us at a possible competitive disadvantage with respect to less leveraged competitors and competitors that have better access to capital resource; and

 

  make us more vulnerable in the event of a further downturn in our business.

 

There can be no assurance that we will be able to meet our debt service obligations, including our obligations under the Notes.

 

We may not be able to satisfy a change in control offer.

 

The indenture governing the Notes contains provisions that apply to a change in control of LTX. If someone triggers a fundamental change as defined in the indenture, we may be required to offer to purchase the Notes with cash. If we have to make that offer, we cannot be sure that we will have enough funds to pay for all the Notes that the holders could tender.

 

We may not be able to pay our debt and other obligations.

 

If our cash flow is inadequate to meet our obligations, we could face substantial liquidity problems. In particular, our 4.25% convertible notes mature in August 2006. Our line of credit and credit facility mature on an annual basis and will expire in November 2004 and July 2005, respectively, if not renewed by us and the issuing bank. If we are unable to generate sufficient cash flow or otherwise obtain funds necessary to make required payment of our 4.25% convertible notes, or certain or our other obligations, we would be in default under the terms thereof, which could permit the holders of those obligations to accelerate their maturity and also could cause default under future indebtedness we may incur. Any such default could have material adverse effect on our business, prospects, financial position and operating results. In addition, we may not be able to repay amounts due in respect of our 4.25% convertible notes if payment of those obligations were to be accelerated following the occurrence of any other event of default as defined in the instruments creating those obligations. Moreover, we may not have sufficient funds or be able to arrange for financing to pay the principal amount of our 4.25% convertible notes at their maturity.

 

We may need additional financing, which could be difficult to obtain.

 

We expect that our existing cash and marketable securities, and borrowings from available bank financings, will be sufficient to meet our cash requirements to fund operations and expected capital expenditures for the foreseeable future. In the event, we may need to raise additional funds, we cannot be certain that we will be able to obtain such additional financing on favorable terms if at all. Further, if we issue additional equity securities, stockholders may experience additional dilution or the new equity securities may have rights, preferences or privileges senior to those of existing holders of common stock. Future financings may place restrictions on how we operate our business. If we cannot raise funds on acceptable terms, if and when needed, we may not be able to develop or enhance our products and services, take advantage of future opportunities, grow our business or respond to competitive pressures, which could seriously harm our business.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

 

There has been no material change in the Company’s Market Risk exposure since the filing of the 2004 Annual Report on Form 10-K.

 

Item 4. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures. Based on the evaluation by management, with the participation of the Chief Executive Officer and Chief Financial Officer, of our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of the end of the period covered by this quarterly report on Form 10-Q, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that the Company’s disclosure controls and procedures (1) were designed to ensure that material information relating to the Company, including its consolidated subsidiaries, was made known to them by others within those entities, particularly during the period in which this report was being prepared and (2) effective, in that they provide reasonable assurance that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act, including information regarding its consolidated subsidiaries, is recorded, processed, summarized and reported within the time periods specified by the SEC.

 

22


Table of Contents

Changes in Internal Controls. No change in the Company’s internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurred during the fiscal quarter ended October 31, 2004 that has materially affected or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

Limitations on the Effectiveness of Controls

 

The Company’s management, including the Chief Executive Officer and Chief Financial Officer, does not expect that the Company’s disclosure controls and procedures or the Company’s internal controls can prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. The inherent limitations in all control systems include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons or by collusion of two or more people. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

 

PART II - OTHER INFORMATION

 

Item 4. Submission of Matters to a Vote of Security Holders

 

  (a) The Company held its Annual Meeting of Stockholders on December 8, 2004.

 

  (b) Stockholders elected Messrs. Mark S. Ain and Samuel Rubinovitz as Class III Directors to serve additional terms of three years. Messrs. Richard S. Hill, Stephen M. Jennings and Robert E. Moore continued to serve as Class I Directors, with their terms of office expiring at the 2005 Annual Meeting of Stockholders. Messrs. Roger W. Blethen, Robert J. Boehlke and Roger J. Maggs continued to serve as Class II Directors, with their terms of office expiring at the 2006 Annual Meeting of Stockholders.

 

  (c) Matters voted upon and the results of the voting were are follows:

 

  i. Stockholders voted 49,372,190 shares FOR and 6,381,544 shares WITHHELD from the election of Mark S. Ain as a Class III Director. Stockholders voted 51,670,948 shares FOR and 4,082,786 shares WITHHELD from the election of Samuel Rubinovitz as a Class III Director.

 

  ii. Stockholders voted 24,680,283 shares FOR, 14,907,793 AGAINST and 104,643 shares ABSTAINED regarding the vote to approve the LTX Corporation 2004 Stock Plan.

 

23


Table of Contents

Item 5. Other Information

 

(a) The 2004 Stock Plan was approved by the stockholders of the Company on December 8, 2004. A description of the 2004 Stock Plan, along with a copy thereof, was included in the Company’s Proxy Statement dated November 5, 2004 furnished in connection with the Annual Meeting of Stockholders held on December 8, 2004 (the “Proxy Statement”). A copy of the 2004 Stock Plan is attached hereto as Exhibit 10.15 and is incorporated herein by reference. The form of Nonstatutory Stock Option Agreement for Non-Employee Directors is attached hereto as Exhibit 10.16 and the form of Incentive Stock Option Agreement for Executives is attached hereto as Exhibit 10.17; both are incorporated herein by reference.

 

(b) At a meeting on December 8, 2004, the Board of Directors, based on the recommendation of the Corporate Governance and Nominating Committee, appointed the Audit Committee, the Compensation Committee, and the Corporate Governance and Nominating Committee, as well as each such committees’ members for the year. The Board also set the annual compensation for non-employee directors of the Board (as set forth below) and granted an option for 20,000 shares of Company common stock at a fair market exercise price to Roger Maggs in consideration of his continuing service as a director.

 

Non-employee Director Annual Compensation:

 

  A $20,000 annual retainer;

 

  a fee of $3,000 for each directors meeting attended;

 

  a fee of $1,000 for each committee meeting attended (or, if chairman of the Audit or the Compensation Committee, $3,000 and $2,000 respectively);

 

  a grant of an option to purchase 9,500 shares of Company common stock in each year served as a member of the Board;

 

  a grant of an option to purchase 1,500 shares of Company common stock in each year served as a member of a committee of the Board (or 3,000 in each year served as a chairman);

 

  reimbursement of travel expenses for attending meetings.

 

Item 6. Exhibits and Reports on Form 8-K

 

(a)

 

  (i) Exhibit 10.15+ 2004 Stock Plan

 

  (ii) Exhibit 10.16 Form of Nonstatutory Stock Option Agreement for Non-Employee Directors

 

  (iii) Exhibit 10.17 Form of Incentive Stock Option Agreement for Executives

 

  (iv) Exhibit 31.1 and 31.2 Rule 13a-14(a)/15d-14(a) Certifications

 

  (v) Exhibit 32 Section 1350 Certifications

 

(b)

 

  (i) On September 20, 2004, the Company furnished a current report on Form 8-K under Item 2 (Costs Associated with Exit or Disposal Activities) describing its reorganization actions for the fiscal quarter ended October 31, 2004.

 

  (ii) On August 26, 2004, the Company furnished a current report on Form 8-K under Item 12 (Results of Operations and Financial Condition) describing and furnishing the press release announcing its earnings for the fiscal quarter ended July 31, 2004, which press release included its consolidated financial statements for the period.

 

24


Table of Contents

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

   

LTX Corporation

Date: December 9, 2004

 

By:

 

/s/ Mark J. Gallenberger


       

Mark J. Gallenberger

       

Chief Financial Officer and Treasurer

       

(Principal Financial Officer)

 

25

Exhibit 10.15

 

LTX CORPORATION

 

2004 STOCK PLAN

 

1. Purpose

 

The purpose of this 2004 Stock Plan (the “Plan”) of LTX Corporation, a Massachusetts corporation (the “Company”), is to advance the interests of the Company’s stockholders by enhancing the Company’s ability to attract, retain and motivate persons who are expected to make important contributions to the Company and by providing such persons with equity ownership opportunities and performance-based incentives that are intended to align their interests with those of the Company’s stockholders. Except where the context otherwise requires, the term “Company” shall include any of the Company’s present or future parent or subsidiary corporations as defined in Sections 424(e) or (f) of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”) and any other business venture (including, without limitation, joint venture or limited liability company) in which the Company has a controlling interest, as determined by the Board of Directors of the Company (the “Board”).

 

2. Eligibility

 

All of the Company’s employees, officers, directors, consultants and advisors are eligible to receive options, stock appreciation rights, restricted stock and other stock-based awards (each, an “Award”) under the Plan. Each person who receives an Award under the Plan is deemed a “Participant”.

 

3. Administration and Delegation

 

(a) Administration by Board of Directors . The Plan will be administered by the Board. The Board shall have authority to grant Awards and to adopt, amend and repeal such administrative rules, guidelines and practices relating to the Plan as it shall deem advisable. The Board may correct any defect, supply any omission or reconcile any inconsistency in the Plan or any Award in the manner and to the extent it shall deem expedient to carry the Plan into effect and it shall be the sole and final judge of such expediency. All decisions by the Board shall be made in the Board’s sole discretion and shall be final and binding on all persons having or claiming any interest in the Plan or in any Award. No director or person acting pursuant to the authority delegated by the Board shall be liable for any action or determination relating to or under the Plan made in good faith.

 

(b) Appointment of Committees . To the extent permitted by applicable law, the Board may delegate any or all of its powers under the Plan to one or more committees or subcommittees of the Board (a “Committee”). All references in the Plan to the “Board” shall mean the Board or a Committee of the Board to the extent that the Board’s powers or authority under the Plan have been delegated to such Committee.

 

4. Stock Available for Awards

 

(a) Number of Shares . Subject to adjustment under Section 10, Awards may be made under the Plan for up to 4,000,000 shares of common stock, $.05 par value per share, of the Company (the “Common Stock”). In addition, any unissued shares of Common Stock and any unused shares of Common Stock as a result of termination, surrender, cancellation or forfeiture of options under the Company’s 2001 Stock Plan and the Company’s 1999 Stock Plan (together, the “Existing Plans”) will be available for grant under this Plan, subject, in the case of incentive stock options to any limits under the Internal Revenue Code. As of October 12, 2004, options to purchase 7,647,554 shares of Common Stock were outstanding under the Existing Plans and an additional 116,350 shares of Common Stock were reserved for future issuance. If this Plan is approved by the Company’s stockholders, no additional grants will be made under either of the Existing Plans.


If any Award expires or is terminated, surrendered or canceled without having been fully exercised or is forfeited in whole or in part (including as the result of shares of Common Stock subject to such Award being repurchased by the Company at the original issuance price pursuant to a contractual repurchase right) or results in any Common Stock not being issued, the unused Common Stock covered by such Award shall again be available for the grant of Awards under the Plan. Further, shares of Common Stock tendered to the Company by a Participant to exercise an Award shall be added to the number of shares of Common Stock available for the grant of Awards under the Plan. However, in the case of Incentive Stock Options (as hereinafter defined), the foregoing provisions shall be subject to any limitations under the Code. Shares issued under the Plan may consist in whole or in part of authorized but unissued shares or treasury shares.

 

(b) Sub-limits . Subject to adjustment under Section 10, the maximum number of shares of Common Stock with respect to which Awards may be granted to any Participant under the Plan shall be 500,000 per fiscal year of the Company. For purposes of the foregoing limit, the combination of an Option in tandem with an SAR (as each is hereafter defined) shall be treated as a single Award. The per-Participant limit described in this Section 4(b)(1) shall be construed and applied consistently with Section 162(m) of the Code or any successor provision thereto, and the regulations thereunder (“Section 162(m)”).

 

5. Stock Options

 

(a) General . The Board may grant options to purchase Common Stock (each, an “Option”) and determine the number of shares of Common Stock to be covered by each Option, the exercise price of each Option and the conditions and limitations applicable to the exercise of each Option, including conditions relating to applicable federal or state securities laws, as it considers necessary or advisable. An Option which is not intended to be an Incentive Stock Option (as hereinafter defined) shall be designated a “Nonstatutory Stock Option”.

 

(b) Incentive Stock Options . An Option that the Board intends to be an “incentive stock option” as defined in Section 422 of the Code (an “Incentive Stock Option”) shall only be granted to employees of LTX Corporation, any of LTX Corporation’s present or future parent or subsidiary corporations as defined in Sections 424(e) or (f) of the Code, and any other entities the employees of which are eligible to receive Incentive Stock Options under the Code, and shall be subject to and shall be construed consistently with the requirements of Section 422 of the Code. The Company shall have no liability to a Participant, or any other party, if an Option (or any part thereof) that is intended to be an Incentive Stock Option is not an Incentive Stock Option or for any action taken by the Board pursuant to Section 11(f), including without limitation the conversion of an Incentive Stock Option to a Nonstatutory Stock Option.

 

(c) Exercise Price . The Board shall establish the exercise price of each Option and specify such exercise price in the applicable option agreement. The exercise price of an Option for a share of Common Stock shall not be less than fair market value as determined by (or in a manner approved by) the Board (“Fair Market Value”) of a share of Common Stock on the date of the grant of such Option.

 

(d) Duration of Options . Each Option shall be exercisable at such times and subject to such terms and conditions as the Board may specify in the applicable option agreement.

 

(e) Exercise of Option . Options may be exercised by delivery to the Company of a written notice of exercise signed by the proper person or by any other form of notice (including electronic notice) approved by the Board together with payment in full as specified in Section 5(f) for the number of shares for which the Option is exercised. Shares of Common Stock subject to the Option will be delivered by the Company following exercise either as soon as practicable or, subject to such conditions as the Board shall specify, on a deferred basis (with the Company’s obligation to be evidenced by an instrument providing for future delivery of the deferred shares at the time or times specified by the Board).


(f) Payment upon Exercise . Common Stock purchased upon the exercise of an Option granted under the Plan shall be paid for as follows:

 

(1) in cash or by check, payable to the order of the Company;

 

(2) except as the Board may otherwise provide in an option agreement, by (i) delivery of an irrevocable and unconditional undertaking by a creditworthy broker to deliver promptly to the Company sufficient funds to pay the exercise price and any required tax withholding or (ii) delivery by the Participant to the Company of a copy of irrevocable and unconditional instructions to a creditworthy broker to deliver promptly to the Company cash or a check sufficient to pay the exercise price and any required tax withholding;

 

(3) when the Common Stock is registered under the Securities Exchange Act of 1934 (the “Exchange Act”), by delivery of shares of Common Stock owned by the Participant valued at their Fair Market Value, provided (i) such method of payment is then permitted under applicable law, (ii) such Common Stock, if acquired directly from the Company, was owned by the Participant for such minimum period of time, if any, as may be established by the Board in its discretion and (iii) such Common Stock is not subject to any repurchase, forfeiture, unfulfilled vesting or other similar requirements;

 

(4) to the extent permitted by applicable law and by the Board, by payment of such other lawful consideration as the Board may determine; or

 

(5) by any combination of the above permitted forms of payment.

 

(g) Substitute Options . In connection with a merger or consolidation of an entity with the Company or the acquisition by the Company of property or stock of an entity, the Board may grant Options in substitution for any options or other stock or stock-based awards granted by such entity or an affiliate thereof. Substitute Options may be granted on such terms as the Board deems appropriate in the circumstances, notwithstanding any limitations on Options contained in the other sections of this Section 5 or in Section 2.

 

(h) Limitation on Repricing . Unless such action is approved by the Company’s stockholders: (1) no outstanding Option granted under the Plan may be amended to provide an exercise price per share that is lower than the then-current exercise price per share of such outstanding Option (other than adjustments pursuant to Section 10); and (2) the Board may not cancel any outstanding Option and grant in substitution therefor new Awards under the Plan covering the same or a different number of shares of Common Stock and having an exercise price per share lower than the then-current exercise price per share of the cancelled Option.

 

6. Director Options

 

(a) Initial Grant . Upon the commencement of service on the Board by any individual who is not then an employee of the Company or any subsidiary of the Company, the Company shall grant to such person a Nonstatutory Stock Option to purchase 20,000 shares of Common Stock (subject to adjustment under Section 10).

 

(b) Annual Grant . On the date of each annual meeting of stockholders of the Company, the Company shall grant to each member of the Board of Directors of the Company who is both serving as a director of the Company immediately prior to and immediately following such annual meeting and who is not then an employee of the Company or any of its subsidiaries, a Nonstatutory Stock Option to purchase 8,000 shares of Common Stock (subject to adjustment under Section 10).

 

(c) Committee Service Grant . On the date on which the Board of Directors annually establishes the Committees of the Board, the Company shall grant to each member of the Board of Directors who is not an employee of the Company or any subsidiary of the Company, a Nonstatutory Stock


Option to purchase 3,000 shares of Common Stock for each Committee on which the member serves as chairman and a Nonstatutory Stock Option to purchase 1,500 shares of Common Stock for each Committee on which the member serves other than as chairman.

 

(d) Terms of Director Options . Options granted under this Section 6 shall (i) have an exercise price per share of Common Stock equal to the Fair Market Value of a share of Common Stock on the date of the grant of such Option, (ii) vest cumulatively as to 20% of the number of shares covered by the Option on the first anniversary of the date of grant, as to 35% of the number of shares covered by the Option on the second anniversary of the date of grant and as to 45% of the number of shares covered by the Option on the third anniversary of the date of grant, in each case provided that the individual is serving on the Board on such date, provided that no additional vesting shall take place after the Participant ceases to serve as a director and further provided that the Board may provide for accelerated vesting in the case of death or disability (iii) expire on the earlier of 10 years from the date of grant or one year following cessation of service on the Board and (iv) contain such other terms and conditions as the Board shall determine. Notwithstanding anything herein to the contrary, in the event that any Participant standing for re-election is not re-elected to the Board of Directors at any meeting or upon the retirement of a Participant from the Board of Directors, all of the Participant’s Options granted under this Section 6 shall become immediately exercisable.

 

(e) Board Discretion . The Board retains the specific authority to from time to time increase or decrease the number of option shares granted under this Section 6, to make additional grants or decline to make a grant, or to provide that the terms and conditions of such grant shall differ from the terms and conditions set forth in Section 6(d) above.

 

7. Stock Appreciation Rights

 

(a) General . A Stock Appreciation Right, or SAR, is an Award entitling the holder, upon exercise, to receive an amount in cash or Common Stock or a combination thereof (such form to be determined by the Board) determined in whole or in part by reference to appreciation, from and after the date of grant, in the fair market value of a share of Common Stock. SARs may be based solely on appreciation in the fair market value of Common Stock or on a comparison of such appreciation with some other measure of market growth such as (but not limited to) appreciation in a recognized market index. The date as of which such appreciation or other measure is determined shall be the exercise date unless another date is specified by the Board in the SAR Award.

 

(b) Grants . Stock Appreciation Rights may be granted in tandem with, or independently of, Options granted under the Plan.

 

(1) Tandem Awards . When Stock Appreciation Rights are expressly granted in tandem with Options, (i) the Stock Appreciation Right will be exercisable only at such time or times, and to the extent, that the related Option is exercisable (except to the extent designated by the Board in connection with a Reorganization Event or a Change in Control Event) and will be exercisable in accordance with the procedure required for exercise of the related Option; (ii) the Stock Appreciation Right will terminate and no longer be exercisable upon the termination or exercise of the related Option, except to the extent designated by the Board in connection with a Reorganization Event or a Change in Control Event and except that a Stock Appreciation Right granted with respect to less than the full number of shares covered by an Option will not be reduced until the number of shares as to which the related Option has been exercised or has terminated exceeds the number of shares not covered by the Stock Appreciation Right; (iii) the Option will terminate and no longer be exercisable upon the exercise of the related Stock Appreciation Right; and (iv) the Stock Appreciation Right will be transferable only with the related Option.

 

(2) Independent SARs . A Stock Appreciation Right not expressly granted in tandem with an Option will become exercisable at such time or times, and on such conditions, as the Board may specify in the SAR Award.

 

(c) Exercise . Stock Appreciation Rights may be exercised by delivery to the Company of a written notice of exercise signed by the proper person or by any other form of notice (including electronic notice) approved by the Board, together with any other documents required by the Board.


8. Restricted Stock

 

(h) General . The Board may grant Awards entitling recipients to acquire shares of Common Stock, subject to the right of the Company to repurchase all or part of such shares at their issue price or other stated or formula price (or to require forfeiture of such shares if issued at no cost) from the recipient in the event that conditions specified by the Board in the applicable Award are not satisfied prior to the end of the applicable restriction period or periods established by the Board for such Award (each, a “Restricted Stock Award”).

 

(i) Terms and Conditions . The Board shall determine the terms and conditions of a Restricted Stock Award, including the conditions for repurchase (or forfeiture) and the issue price, if any.

 

(j) Stock Certificates . Any stock certificates issued in respect of a Restricted Stock Award shall be registered in the name of the Participant and, unless otherwise determined by the Board, deposited by the Participant, together with a stock power endorsed in blank, with the Company (or its designee). At the expiration of the applicable restriction periods, the Company (or such designee) shall deliver the certificates no longer subject to such restrictions to the Participant or if the Participant has died, to the beneficiary designated, in a manner determined by the Board, by a Participant to receive amounts due or exercise rights of the Participant in the event of the Participant’s death (the “Designated Beneficiary”). In the absence of an effective designation by a Participant, “Designated Beneficiary” shall mean the Participant’s estate.

 

(k) Deferred Delivery of Shares . The Board may, at the time any Restricted Stock Award is granted, provide that, at the time Common Stock would otherwise be delivered pursuant to the Award, the Participant shall instead receive an instrument evidencing the right to future delivery of Common Stock at such time or times, and on such conditions, as the Board shall specify. The Board may at any time accelerate the time at which delivery of all or any part of the Common Stock shall take place. The Board may also permit an exchange of unvested shares of Common Stock that have already been delivered to a Participant for an instrument evidencing the right to future delivery of Common Stock at such time or times, and on such conditions, as the Board shall specify.

 

9. Other Stock-Based Awards

 

Other Awards of shares of Common Stock, and other Awards that are valued in whole or in part by reference to, or are otherwise based on, shares of Common Stock or other property, may be granted hereunder to Participants (“Other Stock Unit Awards”), including without limitation Awards entitling recipients to receive shares of Common Stock to be delivered in the future. Such Other Stock Unit Awards shall also be available as a form of payment in the settlement of other Awards granted under the Plan or as payment in lieu of compensation to which a Participant is otherwise entitled. Other Stock Unit Awards may be paid in shares of Common Stock or cash, as the Board shall determine. Subject to the provisions of the Plan, the Board shall determine the conditions of each Other Stock Unit Awards, including any purchase price applicable thereto. At the time any Award is granted, the Board may provide that, at the time Common Stock would otherwise be delivered pursuant to the Award, the Participant will instead receive an instrument evidencing the Participant’s right to future delivery of the Common Stock.

 

10. Adjustments for Changes in Common Stock and Certain Other Events

 

(h) Changes in Capitalization . In the event of any stock split, reverse stock split, stock dividend, recapitalization, combination of shares, reclassification of shares, spin-off or other similar change in capitalization or event, or any distribution to holders of Common Stock other than an ordinary cash dividend, (i) the number and class of securities available under this Plan, (ii) the sub-limits set forth in Section 4(b), (iii) the number and class of securities and exercise price per share of each outstanding Option and each Option issuable under Section 6, (iv) the share- and per-share provisions of each Stock


Appreciation Right, (v) the repurchase price per share subject to each outstanding Restricted Stock Award and (vi) the share- and per-share-related provisions of each outstanding Other Stock Unit Award, shall be appropriately adjusted by the Company (or substituted Awards may be made, if applicable) to the extent determined by the Board.

 

(i) Reorganization and Change in Control Events .

 

(1) Definitions .

 

  (a) A “Reorganization Event” shall mean:

 

  (i) any merger or consolidation of the Company with or into another entity as a result of which all of the Common Stock of the Company is converted into or exchanged for the right to receive cash, securities or other property or is cancelled;

 

  (ii) any exchange of all of the Common Stock of the Company for cash, securities or other property pursuant to a share exchange transaction; or

 

  (iii) any liquidation or dissolution of the Company.

 

  (b) A “Change in Control Event” shall mean:

 

  (i) The acquisition by any individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”))(a “Person”) of beneficial ownership (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of 20% or more of either (a) the then outstanding shares of stock (the “Outstanding Company Common Stock”) or (b) the combined voting power of the then outstanding voting securities of the Company entitled to vote generally in the election of directors (the “Outstanding Company Voting Securities”); provided, however, that for purposes of this subsection (i), the following acquisitions shall not constitute a Change of Control: (A) any acquisition directly from the Company, (B) any acquisition by the Company, (C) any acquisition by any employee benefit plan (or related trust) sponsored or maintained by the Company or any corporation controlled by the Company or (D) any acquisition pursuant to a transaction which complies with clauses (A), (B) and (C) of subsection (iii) of this Section 10; or

 

  (ii) Individuals who, as of the date of initial adoption of this Plan by the Board, constitute the Board (the “Incumbent Board”) cease for any reason to constitute at least a majority of the Board; provided, however, that any individual becoming a director subsequent to the date of initial adoption of this Plan by the Board whose election, or nomination for election by the Company’s stockholders, was approved by a vote of at least a majority of the directors then comprising the Incumbent Board shall be considered as though such individual were a member of the Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a


result of an actual or threatened election contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board; or

 

  (iii) Consummation of a reorganization, merger, consolidation or sale or other disposition of all or substantially all of the assets of the Company or the acquisition of assets of another entity (a “Corporate Transaction”), in each case, unless, following such Corporate Transaction, (A) all or substantially all of the individuals and entities who were the beneficial owners, respectively, of the Outstanding Company Common Stock and Outstanding Company Voting Securities immediately prior to such Corporate Transaction beneficially own, directly or indirectly, more than 60% of, respectively, the then outstanding shares of common stock and the combined voting power of the then outstanding voting securities entitled to vote generally in the election of directors, as the case may be, of the corporation resulting from such Corporate Transaction (including, without limitation, a corporation which as a result of such transaction owns the Company or all or substantially all of the Company’s assets either directly or through one or more subsidiaries) in substantially the same proportions as their immediately prior to such Corporate Transaction of the Outstanding Company Common Stock and Outstanding Company Voting Securities, as the case may be, (B) no Person (excluding any employee benefit plan (or related trust) of the Company or such corporation resulting from such Corporate Transaction) beneficially owns, directly or indirectly, 20% or more of, respectively, the then outstanding shares of common stock of the corporation resulting from such Corporate Transaction or the combined voting power of the then outstanding voting of such corporation except to the extent that such ownership existed prior to the Corporate Transaction and (C) at least a majority of the members of the Board of Directors of the corporation resulting from such Corporate Transaction were members of the Incumbent Board at the time of the execution of the initial agreement, or of the action of the Board, providing for such Corporate Transaction; or

 

  (iv) Approval by the stockholders of the Company of a complete liquidation or dissolution of the Company.

 

  (c) “Cause” shall mean any (i) willful failure by the Participant, which failure is not cured within 30 days of written notice to the Participant from the Company, to perform his or her material responsibilities to the Company or (ii) willful misconduct by the Participant which affects the business reputation of the Company. The Participant shall be considered to have been discharged for “Cause” if the Company determines, within 30 days after the Participant’s resignation, that discharge for Cause was warranted.


(2) Effect on Options .

 

  (a) Reorganization Event . Upon the occurrence of a Reorganization Event (regardless of whether such event also constitutes a Change in Control Event), or the execution by the Company of any agreement with respect to a Reorganization Event (regardless of whether such event will result in a Change in Control Event), the Board shall provide that all outstanding Options shall be assumed, or equivalent options shall be substituted, by the acquiring or succeeding corporation (or an affiliate thereof), provided that if such Reorganization Event also constitutes a Change in Control Event, except to the extent specifically otherwise provided in the instrument evidencing any Option or any other agreement between a Participant and the Company, the right to purchase shares subject to the assumed or substituted option shall continue to become vested in accordance with the original vesting schedule set forth in such Option, and such assumed or substituted options shall become immediately vested and exercisable in full if, on or prior to the 12 (twelve)-month anniversary of the date of the occurrence of the Reorganization Event, the Participant’s employment or other relationship with the Company or the acquiring or succeeding corporation is terminated without Cause by the Company or the acquiring or succeeding corporation. For purposes hereof, an Option shall be considered to be assumed if, following occurrence of the Reorganization Event, the Option confers the right to purchase, for each share of Common Stock subject to the Option immediately prior to the occurrence of the Reorganization Event, the consideration (whether cash, securities or other property) received as a result of the Reorganization Event by holders of Common Stock for each share of Common Stock held immediately prior to the occurrence of the Reorganization Event (and if holders were offered a choice of consideration, the type of consideration chosen by the holders of a majority of the outstanding shares of Common Stock); provided, however, that if the consideration received as a result of the Reorganization Event is not solely common stock of the acquiring or succeeding corporation (or an affiliate thereof), the Company may, with the consent of the acquiring or succeeding corporation, provide for the consideration to be received upon the exercise of Options to consist solely of common stock of the acquiring or succeeding corporation (or an affiliate thereof) equivalent in fair market value to the per share consideration received by holders of outstanding shares of Common Stock as a result of the Reorganization Event.

 

Notwithstanding the foregoing, if the acquiring or succeeding corporation (or an affiliate thereof) does not agree to assume, or substitute for, such Options, or in the event of a liquidation or dissolution of the Company, the Board shall, upon written notice to the Participants, provide that all then unexercised Options will become exercisable in full as of a specified time prior to the Reorganization Event and will terminate immediately prior to the occurrence of such Reorganization Event, except to the extent exercised by the Participants before the occurrence of such Reorganization Event; provided, however, that in the event of a Reorganization Event under the terms of which holders of Common Stock will receive upon occurrence thereof a cash payment for each share of Common Stock surrendered pursuant to such Reorganization Event (the “Acquisition Price”), then the Board may instead provide that all outstanding Options shall terminate upon occurrence of such Reorganization Event and that each Participant shall receive, in exchange therefor, a cash payment equal to the amount (if


any) by which (A) the Acquisition Price multiplied by the number of shares of Common Stock subject to such outstanding Options (whether or not then exercisable), exceeds (B) the aggregate exercise price of such Options.

 

  (b) Change in Control Event that is not a Reorganization Event . Upon the consummation of a Change in Control Event that does not also constitute a Reorganization Event, except to the extent specifically provided to the contrary in the instrument evidencing any Option or any other agreement between a Participant and the Company, the right to purchase shares subject to the Option shall continue to become vested in accordance with the original vesting schedule set forth in such Option; provided, however, that each such Option shall be immediately exercisable in full if, on or prior to the 12 (twelve)-month anniversary of the date of the occurrence of the Change in Control Event, the Participant’s employment or other relationship with the Company or the acquiring or succeeding corporation is terminated without Cause by the Company or the acquiring or succeeding corporation.

 

(3) Effect on Restricted Stock Awards .

 

  (a) Reorganization Event that is not a Change in Control Event . Upon the occurrence of a Reorganization Event that is not a Change in Control Event, the repurchase and other rights of the Company under each outstanding Restricted Stock Award shall inure to the benefit of the Company’s successor and shall apply to the cash, securities or other property which the Common Stock was converted into or exchanged for pursuant to such Reorganization Event in the same manner and to the same extent as they applied to the Common Stock subject to such Restricted Stock Award.

 

  (b) Change in Control Event . Upon the consummation of a Change in Control Event (regardless of whether such event also constitutes a Reorganization Event), except to the extent specifically provided to the contrary in the instrument evidencing any Restricted Stock Award or any other agreement between a Participant and the Company, shares shall continue to become free from conditions or restrictions in accordance with the original schedule set forth in such Restricted Stock Award. In addition, each such Restricted Stock Award shall immediately become free from all conditions or restrictions if, on or prior to the 12 (twelve)-month anniversary of the date of the occurrence of the Change in Control Event, the Participant’s employment or other relationship with the Company or the acquiring or succeeding corporation is terminated without Cause by the Company or the acquiring or succeeding corporation.

 

(4) Effect on Stock Appreciation Rights and Other Stock Unit Awards .

 

The Board may specify in an Award at the time of the grant the effect of a Reorganization Event and Change in Control Event on any SAR and Other Stock Unit Award.

 

11. General Provisions Applicable to Awards

 

(h) Transferability of Awards . Except as the Board may otherwise determine or provide in an Award, Awards shall not be sold, assigned, transferred, pledged or otherwise encumbered by the person to


whom they are granted, either voluntarily or by operation of law, except by will or the laws of descent and distribution or, other than in the case of an Incentive Stock Option, pursuant to a qualified domestic relations order, and, during the life of the Participant, shall be exercisable only by the Participant. References to a Participant, to the extent relevant in the context, shall include references to authorized transferees.

 

(i) Documentation . Each Award shall be evidenced in such form (written, electronic or otherwise) as the Board shall determine. Each Award may contain terms and conditions in addition to those set forth in the Plan.

 

(j) Board Discretion . Except as otherwise provided by the Plan, each Award may be made alone or in addition or in relation to any other Award. The terms of each Award need not be identical, and the Board need not treat Participants uniformly.

 

(k) Termination of Status . The Board shall determine the effect on an Award of the disability, death, retirement, authorized leave of absence or other change in the employment or other status of a Participant and the extent to which, and the period during which, the Participant, or the Participant’s legal representative, conservator, guardian or Designated Beneficiary, may exercise rights under the Award.

 

(l) Withholding . Each Participant shall pay to the Company, or make provision satisfactory to the Company for payment of, any taxes required by law to be withheld in connection with an Award to such Participant. If specifically provided in the agreement evidencing an Award, for so long as the Common Stock is registered under the Exchange Act, Participants may satisfy such tax obligations in whole or in part by delivery of shares of Common Stock, including shares retained from the Award creating the tax obligation, valued at their Fair Market Value; provided, however, except as otherwise provided by the Board, that the total tax withholding where stock is being used to satisfy such tax obligations cannot exceed the Company’s minimum statutory withholding obligations (based on minimum statutory withholding rates for federal and state tax purposes, including payroll taxes, that are applicable to such supplemental taxable income). Shares surrendered to satisfy tax withholding requirements cannot be subject to any repurchase, forfeiture, unfulfilled vesting or other similar requirements. The Company may, to the extent permitted by law, deduct any such tax obligations from any payment of any kind otherwise due to a Participant.

 

(m) Amendment of Award . The Board may amend, modify or terminate any outstanding Award, including but not limited to, substituting therefor another Award of the same or a different type, changing the date of exercise or realization, and converting an Incentive Stock Option to a Nonstatutory Stock Option, provided that the Participant’s consent to such action shall be required unless the Board determines that the action, taking into account any related action, would not materially and adversely affect the Participant.

 

(n) Conditions on Delivery of Stock . The Company will not be obligated to deliver any shares of Common Stock pursuant to the Plan or to remove restrictions from shares previously delivered under the Plan until (i) all conditions of the Award have been met or removed to the satisfaction of the Company, (ii) in the opinion of the Company’s counsel, all other legal matters in connection with the issuance and delivery of such shares have been satisfied, including any applicable securities laws and any applicable stock exchange or stock market rules and regulations, and (iii) the Participant has executed and delivered to the Company such representations or agreements as the Company may consider appropriate to satisfy the requirements of any applicable laws, rules or regulations.

 

(o) Acceleration . The Board may at any time provide that any Award shall become immediately exercisable in full or in part, free of some or all restrictions or conditions, or otherwise realizable in full or in part, as the case may be.


(p) Performance Conditions .

 

(1) This Section 11(i) shall be administered by a Committee approved by the Board, all of the members of which are “outside directors” as defined by Section 162(m) (the “Section 162(m) Committee”).

 

(2) Notwithstanding any other provision of the Plan, if the Section 162(m) Committee determines, at the time a Restricted Stock Award or Other Stock Unit Award is granted to a Participant who is then an officer, that such Participant is, or is likely to be as of the end of the tax year in which the Company would claim a tax deduction in connection with such Award, a Covered Employee (as defined in Section 162(m)), then the Section 162(m) Committee may provide that this Section 11(i) is applicable to such Award.

 

(3) If a Restricted Stock Award or Other Stock Unit Award is subject to this Section 11(i), then the lapsing of restrictions thereon and the distribution of cash or Shares pursuant thereto, as applicable, shall be subject to the achievement of one or more objective performance goals established by the Section 162(m) Committee, which shall be based on the relative or absolute attainment of specified levels of one or any combination of the following: (a) earnings per share, (b) return on average equity or average assets with respect to a pre-determined peer group, (c) earnings, (d) earnings growth, (e) revenues, (f) expenses, (g) stock price, (h) market share, (i) return on sales, assets, equity or investment, (j) regulatory compliance, (k) improvement of financial ratings, (l) achievement of balance sheet or income statement objectives, (m) total shareholder return, (n) net operating profit after tax, (o) pre-tax or after-tax income, (p) cash flow, or (q) such other objective goals established by the Board, and may be absolute in their terms or measured against or in relationship to other companies comparably, similarly or otherwise situated. Such performance goals may be adjusted to exclude any one or more of (i) extraordinary items, (ii) gains or losses on the dispositions of discontinued operations, (iii) the cumulative effects of changes in accounting principles, (iv) the writedown of any asset, and (v) charges for restructuring and rationalization programs. Such performance goals may vary by Participant and may be different for different Awards. Such performance goals shall be set by the Section 162(m) Committee within the time period prescribed by, and shall otherwise comply with the requirements of, Section 162(m).

 

(4) Notwithstanding any provision of the Plan, with respect to any Restricted Stock Award or Other Stock Unit Award that is subject to this Section 11(i), the Section 162(m) Committee may adjust downwards, but not upwards, the cash or number of Shares payable pursuant to such Award, and the Section 162(m) Committee may not waive the achievement of the applicable performance goals except in the case of the death or disability of the Participant.

 

(5) The Section 162(m) Committee shall have the power to impose such other restrictions on Awards subject to this Section 11(i) as it may deem necessary or appropriate to ensure that such Awards satisfy all requirements for “performance-based compensation” within the meaning of Section 162(m)(4)(C) of the Code, or any successor provision thereto.


12. Miscellaneous

 

(a) No Right to Employment or Other Status . No person shall have any claim or right to be granted an Award, and the grant of an Award shall not be construed as giving a Participant the right to continued employment or any other relationship with the Company. The Company expressly reserves the right at any time to dismiss or otherwise terminate its relationship with a Participant free from any liability or claim under the Plan, except as expressly provided in the applicable Award.

 

(b) No Rights as Stockholder . Subject to the provisions of the applicable Award, no Participant or Designated Beneficiary shall have any rights as a stockholder with respect to any shares of Common Stock to be distributed with respect to an Award until becoming the record holder of such shares. Notwithstanding the foregoing, in the event the Company effects a split of the Common Stock by means of a stock dividend and the exercise price of and the number of shares subject to such Option are adjusted as of the date of the distribution of the dividend (rather than as of the record date for such dividend), then an optionee who exercises an Option between the record date and the distribution date for such stock dividend shall be entitled to receive, on the distribution date, the stock dividend with respect to the shares of Common Stock acquired upon such Option exercise, notwithstanding the fact that such shares were not outstanding as of the close of business on the record date for such stock dividend.

 

(c) Effective Date and Term of Plan . The Plan shall become effective on the date on which it is adopted by the Board, but no Award may be granted unless and until the Plan has been approved by the Company’s stockholders. No Awards shall be granted under the Plan after the completion of 10 years from the earlier of (i) the date on which the Plan was adopted by the Board or (ii) the date the Plan was approved by the Company’s stockholders, but Awards previously granted may extend beyond that date.

 

(d) Amendment of Plan . The Board may amend, suspend or terminate the Plan or any portion thereof at any time; provided that, to the extent determined by the Board, no amendment requiring stockholder approval under any applicable legal, regulatory or listing requirement shall become effective until such stockholder approval is obtained. No Award shall be made that is conditioned upon stockholder approval of any amendment to the Plan.

 

(e) Provisions for Foreign Participants . The Board may modify Awards or Options granted to Participants who are foreign nationals or employed outside the United States or establish subplans or procedures under the Plan to recognize differences in laws, rules, regulations or customs of such foreign jurisdictions with respect to tax, securities, currency, employee benefit or other matters.

 

(f) Governing Law . The provisions of the Plan and all Awards made hereunder shall be governed by and interpreted in accordance with the laws of the Commonwealth of Massachusetts, without regard to any applicable conflicts of law.

Exhibit 10.16

 

LTX Corporation

 

Nonstatutory Stock Option Agreement

Granted Under 2004 Stock Plan

 

1. Grant of Option .

 

This agreement evidences the grant by LTX Corporation, a Massachusetts corporation (the “Company”), on                      , 200    (the “Grant Date”) to                      , a director of the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2004 Stock Plan (the “Plan”), a total of              shares (the “Shares”) of common stock, $.05 par value per share, of the Company (“Common Stock”) at $              per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on                          (the “Final Exercise Date”).

 

It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

 

2. Vesting Schedule .

 

This option will become exercisable (“vest”) as follows:

 

Date


  Percentage

     

                     , 200   

  20 %    

                     , 200   

  35 %    

                     , 200   

  45 %    

 

The right of exercise shall be cumulative so that to the extent the option is not exercised in any period to the maximum extent permissible it shall continue to be exercisable, in whole or in part, with respect to all Shares for which it is vested until the earlier of the Final Exercise Date or the termination of this option under Section 3 hereof or the Plan.

 

3. Exercise of Option .

 

(a) Form of Exercise . Each election to exercise this option shall be in writing, signed by the Participant, and received by the Company at its principal office, accompanied by this agreement, and payment in full in the manner provided in the Plan. The Participant may purchase less than the number of shares covered hereby, provided that no partial exercise of this option may be for any fractional share.


(b) Continuous Relationship with the Company Required . Except as otherwise provided in this Section 3, this option may not be exercised unless the Participant, at the time he or she exercises this option, is, and has been at all times since the Grant Date, director of, or consultant or advisor to, the Company or any other entity the directors, consultants, or advisors of which are eligible to receive option grants under the Plan (an “Eligible Participant”).

 

(c) Termination of Relationship with the Company . If the Participant ceases to be an Eligible Participant for any reason, then, except as provided below and in paragraph (d), the right to exercise this option shall terminate three months after such cessation (but in no event after the Final Exercise Date), provided that this option shall be exercisable only to the extent that the Participant was entitled to exercise this option on the date of such cessation. Notwithstanding the foregoing, (i) in the event that the Participant stands for re-election to the Board of Directors and is not re-elected at any meeting, this option shall become immediately vested and exercisable, and the right to exercise this option shall terminate one year after such meeting and (ii) upon the retirement of the Participant from the Board of Directors, this option shall become immediately vested and exercisable and the right to exercise this option shall terminate two years after such retirement.

 

(d) Exercise Period Upon Death or Disability . If the Participant dies or becomes disabled (within the meaning of Section 22(e)(3) of the Code) prior to the Final Exercise Date while he or she is an Eligible Participant, this option shall become immediately vested and exercisable by the Participant (or in the case of death by an authorized transferee) and the right to exercise this option shall terminate two years following the date of death or disability of the Participant.

 

4. Withholding .

 

No Shares will be issued pursuant to the exercise of this option unless and until the Participant pays to the Company, or makes provision satisfactory to the Company for payment of, any federal, state or local withholding taxes required by law to be withheld in respect of this option.

 

5. Nontransferability of Option .

 

This option may not be sold, assigned, transferred, pledged or otherwise encumbered by the Participant, either voluntarily or by operation of law, except by will or the laws of descent and distribution, and, during the lifetime of the Participant, this option shall be exercisable only by the Participant.

 

6. Provisions of the Plan .

 

This option is subject to the provisions of the Plan, a copy of which is furnished to the Participant with this option.

 

-2-


IN WITNESS WHEREOF, the Company has caused this option to be executed under its corporate seal by its duly authorized officer. This option shall take effect as a sealed instrument.

 

    LTX Corporation
Dated:                        By:  

 


    Name:  

 


    Title:  

 


 

-3-


PARTICIPANT’S ACCEPTANCE

 

The undersigned hereby accepts the foregoing option and agrees to the terms and conditions thereof. The undersigned hereby acknowledges receipt of a copy of the Company’s 2004 Stock Plan.

 

PARTICIPANT:

 


Address:

 

 


   

 


 

-4-

Exhibit 10.17

 

LTX Corporation

 

Incentive Stock Option Agreement

Granted Under 2004 Stock Plan

 

1. Grant of Option .

 

This agreement evidences the grant by LTX Corporation, a Massachusetts corporation (the “Company”), on                      , 200_ (the “Grant Date”) to                      , an employee of the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2004 Stock Plan (the “Plan”), a total of                      shares (the “Shares”) of common stock,              par value per share, of the Company (“Common Stock”) at $.05 per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on                          (the “Final Exercise Date”).

 

It is intended that the option evidenced by this agreement shall be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

 

2. Vesting Schedule .

 

This option will become exercisable (“vest”) as follows:

 

Date


   Percentage

     

                     , 200   

   25 %    

                     , 200   

   25 %    

                     , 200   

   25 %    

                     , 200   

   25 %    

 

The right of exercise shall be cumulative so that to the extent the option is not exercised in any period to the maximum extent permissible it shall continue to be exercisable, in whole or in part, with respect to all Shares for which it is vested until the earlier of the Final Exercise Date or the termination of this option under Section 3 hereof or the Plan.

 

3. Exercise of Option .

 

(a) Form of Exercise . Each election to exercise this option shall be in writing, signed by the Participant, and received by the Company at its principal office, accompanied by this agreement, and payment in full in the manner provided in the Plan. The Participant may purchase less than the number of shares covered hereby, provided that no partial exercise of this option may be for any fractional share.


(b) Continuous Relationship with the Company Required . Except as otherwise provided in this Section 3, this option may not be exercised unless the Participant, at the time he or she exercises this option, is, and has been at all times since the Grant Date, an employee or officer of, or consultant or advisor to, the Company or any other entity the employees, officers, directors, consultants, or advisors of which are eligible to receive option grants under the Plan (an “Eligible Participant”).

 

(c) Termination of Relationship with the Company . If the Participant ceases to be an Eligible Participant for any reason, then, except as provided in paragraphs (d) and (e) below, the right to exercise this option shall terminate three months after such cessation (but in no event after the Final Exercise Date), provided that this option shall be exercisable only to the extent that the Participant was entitled to exercise this option on the date of such cessation.

 

(d) Exercise Period Upon Death or Disability . If the Participant dies or becomes disabled (within the meaning of Section 22(e)(3) of the Code) prior to the Final Exercise Date while he or she is an Eligible, this option shall become immediately vested and exercisable by the Participant (or in the case of death by an authorized transferee) and the right to exercise this option shall terminate two years following the date of death or disability of the Participant.

 

(e) Change of Control . If, on or prior to the first anniversary of the date of the consummation of a Change of Control, the Participant’s employment with the Company or the acquiring or succeeding corporation is terminated for Good Reason by the Participant or is terminated without Cause by the Company or the acquiring or succeeding corporation, then any options that have prior to the date of such termination become exercisable, may be exercised at any time within three years after the date of termination, or, if earlier, the last date of the option period.

 

For purposes of this Agreement, “Good Reason” and “Cause” shall have the following definitions:

 

“Good Reason” shall mean any significant diminution in the Participant’s title, authority, status, reporting requirements, or responsibilities from and after such Change in Control, or any reduction in the annual base salary payable to the Participant from and after such Change in Control, or the failure to continue any material compensation or bonus plan or program, or the relocation of the place of business at which the Participant is principally located to a location that is greater than 50 miles from its location immediately prior to such Change in Control.

 

“Cause” shall mean any (i) willful failure by the Participant, which failure is not cured within 30 days of written notice to the Participant from the Company, to perform his or her material responsibilities to the Company (other than any such failure resulting from incapacity due to physical or mental illness or any failure after the Participant gives notice of termination for Good Reason) or (ii) willful misconduct by the Participant which affects the business reputation of the Company. For purposes of the preceding sentence, no act or failure to act by the Participant shall be considered “willful” unless it is done, or omitted to be done, in bad faith and without reasonable belief that the Participant’s action or omission was in the best interests of the Company.

 

-2-


4. Tax Matters .

 

(a) Withholding . No Shares will be issued pursuant to the exercise of this option unless and until the Participant pays to the Company, or makes provision satisfactory to the Company for payment of, any federal, state or local withholding taxes required by law to be withheld in respect of this option.

 

(b) Disqualifying Disposition . If the Participant disposes of Shares acquired upon exercise of this option within two years from the Grant Date or one year after such Shares were acquired pursuant to exercise of this option, the Participant shall notify the Company in writing of such disposition.

 

5. Nontransferability of Option .

 

This option may not be sold, assigned, transferred, pledged or otherwise encumbered by the Participant, either voluntarily or by operation of law, except by will or the laws of descent and distribution, and, during the lifetime of the Participant, this option shall be exercisable only by the Participant.

 

6. Provisions of the Plan .

 

This option is subject to the provisions of the Plan, a copy of which is furnished to the Participant with this option.

 

IN WITNESS WHEREOF, the Company has caused this option to be executed under its corporate seal by its duly authorized officer. This option shall take effect as a sealed instrument.

 

    LTX Corporation
Dated:                    By:  

 


    Name:  

 


    Title:  

 


 

-3-


PARTICIPANT’S ACCEPTANCE

 

The undersigned hereby accepts the foregoing option and agrees to the terms and conditions thereof. The undersigned hereby acknowledges receipt of a copy of the Company’s 2004 Stock Plan.

 

PARTICIPANT:

 


Address:  

 


   

 


 

-4-

Exhibit 31.1

 

Rule 13a-14(a) CERTIFICATION

 

I, Roger W. Blethen, certify that:

 

1. I have reviewed the quarterly report on Form 10-Q of LTX Corporation;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

 

  a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b) [Paragraph omitted in accordance with SEC transition instructions contained in SEC Release 34-47986]

 

  c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusion about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d) Disclosed in this report any change in our internal control over financial reporting that occurred during our most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

 

  a) all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

 

/s/ Roger W. Blethen


Roger W. Blethen

Chairman of the Board and

Chief Executive Officer

 

Dated: December 9, 2004

Exhibit 31.2

 

Rule 13a-14(a) CERTIFICATION

 

I, Mark J. Gallenberger, certify that:

 

1. I have reviewed the quarterly report on Form 10-Q of LTX Corporation;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

 

  a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b) [Paragraph omitted in accordance with SEC transition instructions contained in SEC Release 34-47986]

 

  c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusion about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d) Disclosed in this report any change in our internal control over financial reporting that occurred during our most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

 

  a) all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

 

/s/ Mark J. Gallenberger


Mark J. Gallenberger

Vice President and

Chief Financial Officer and Treasurer

 

Dated: December 9, 2004

Exhibit 32

 

CERTIFICATION PURSUANT TO 18 U.S.C. §1350

 

Pursuant to 18 U.S.C. §1350, each of the undersigned certifies that this quarterly report on Form 10-Q for the period ended October 31, 2004 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of LTX Corporation and its wholly owned subsidiaries.

 

/s/ Roger W. Blethen


Roger W. Blethen

Chairman of the Board and

Chief Executive Officer

 

Dated: December 9, 2004

 

/s/ Mark J. Gallenberger


Mark J. Gallenberger

Vice President and

Chief Financial Officer and Treasurer

 

Dated December 9, 2004